Ch 21 First Defenses
Chapter 21 · The Immune System

The Immune System

Pick a section. Each one opens with a picture, then gives the full detail underneath.

Three lines of defenseThe castle: walls, guards, soldiers. 21.1 Surface barriersA body map of the first line. Spotting the invaderPattern recognition and toll-like receptors. PhagocytosisFive steps: adhere, engulf, fuse, digest, expel. When phagocytosis failsThree problems and the body's answers. The phagocytesNeutrophil, macrophage, dendritic cell. Natural killer cellsChecking cells for "self" and killing the abnormal. InflammationThe alarm, the vessels, the four signs. Phagocyte mobilizationFour steps from bone marrow to the wound. InterferonsAn infected cell warns its neighbors. ComplementThree pathways, one split, three outcomes. FeverResetting the body's thermostat. Second line at a glanceEvery innate internal defense in one chart. Adaptive defensesThe third line: primed first, then specific, systemic, with memory. 21.3 AntigensComplete antigens and haptens. Antigenic determinantsThe parts of an antigen that get bound. Self-antigens: MHCThe proteins that mark your cells as self. Check yourselfExplain-why questions. VideosWatch it move. 21.4 LymphocytesFive steps from bone marrow to a fighting clone. Antigen receptor diversityA billion receptors from shuffled gene segments. T cell educationPositive and negative selection in the thymus. Antigen-presenting cellsDendritic cells, macrophages, B cells. 21.5 B cell activationClonal selection, plasma cells, memory cells. Immunological memoryPrimary versus secondary response. Active and passive immunityWho made the antibodies, and vaccines. AntibodiesThe Y-shaped structure and the five classes. How antibodies workNeutralization, agglutination, precipitation, complement. 21.6 T cell typesCD4 and CD8 cells and what they become. MHC class I and IIHow antigen is held up for T cells. T cell activationTwo signals, anergy, and cytokines. Helper T cellsHow they switch on B cells and CD8 cells. Cytotoxic and regulatory T cellsPerforin, granzymes, NK cells, and the brakes. The whole responseOne virus, all three lines, start to finish. 21.7 ImmunodeficienciesSCID, Hodgkin's lymphoma, and how HIV causes AIDS. Organ transplantsRejection and how it is prevented. Autoimmune diseasesHow self-tolerance fails. HypersensitivitiesTypes I to IV, allergies and anaphylaxis. Across the lifespanFrom embryo to old age.
Big picture

Three lines of defense, in the order a pathogen meets them

Picture the body as a medieval castle under attack.

pathogen enters
INNATE (nonspecific) = lines 1 and 2
ADAPTIVE (specific) = line 3
skin + mucosae secretions
1

Surface barriers

Innate (nonspecific)
  • Walls and moat. Structural barriers that keep the invaders out.
  • Intact skin and mucous membranes (mucosae), plus their secretions, such as mucus or tears. The secretions are the moat.
guard breach
2

Innate internal defenses

Innate (nonspecific)
  • Guards. Always present, which is why they are called innate. Like guards, always patrolling. They check everything they meet as friend or foe and attack anything not recognized as "friend". Most can attack directly and, if necessary, call for reinforcements.
  • Called into action whenever the first line has been penetrated, ready to defend against any invaders that get past it. Their job is to inhibit the invaders' spread throughout the body.
  • Chemicals: antimicrobial proteins such as interferons (IFNs) and complement proteins. Cells: phagocytes and natural killer cells (NKs). Processes: inflammation, which involves secretions and recruits white blood cells, and fever.
  • Hallmark: inflammation.
BT one target
3

Adaptive defenses

Adaptive (specific)
  • Soldiers. An elite fighting force equipped with high-tech weapons to attack identified enemies. Slow to mobilize: it must be called into readiness, and it is trained to fight a particular army of invaders. Attacks only known enemies.
  • Attacks particular foreign substances. Takes considerably longer to mount than the innate response. Has memory.
  • B lymphocytes give humoral immunity. T lymphocytes give cellular immunity.

The details

Innate and adaptive defenses are intertwined

Line 1 · Surface barriers

21.1 Where the barriers are

Surface barriers are the skin and the mucous membranes, along with their secretions. This first line is highly effective. Mucous membranes line every body cavity that opens to the exterior: the digestive, respiratory, urinary and reproductive tracts. Intact mucosae form a mechanical barrier inside the body similar to the skin's, preventing the entry of pathogens. Find the number on the body, then read what guards that spot.

Physical barrier Chemical: inhibits or destroys Listed as both
1 2 3 4 5 6 7
  1. 1

    Skin

    • Keratinized epidermis. A heavily keratinized epithelial membrane. As long as it is unbroken, it is a formidable physical barrier to most microorganisms and keeps out pathogens and other harmful substances. Keratin resists most weak acids and bases (alkalis), bacterial enzymes and toxins.
    • Acid mantle. Skin secretions (sweat and sebum) make the epidermal surface acidic, which inhibits bacterial growth. They also contain various bactericidal chemicals.
    • Defensins. Broad-spectrum antimicrobial peptides, secreted in small amounts by skin and mucous membranes. They work in various ways, such as disrupting microbial membranes, and help control bacterial and fungal colonization in the exposed areas. Output increases dramatically in response to inflammation when the surface barriers are breached.
    • Sebum lipids and dermcidin. Some lipids in sebum, and dermcidin in eccrine sweat, are toxic to bacteria (your slides: toxic to some bacteria).
  2. 2

    Eyes

    • Lysozyme in tears. Lacrimal fluid contains lysozyme, an enzyme that destroys microorganisms. It hydrolyzes the peptidoglycan cell wall of bacteria. Tears also continuously lubricate and cleanse the eyes.
  3. 3

    Nose

    • Nasal hairs. A structural modification of the respiratory tract mucosa. Tiny mucus-coated hairs inside the nose filter and trap inhaled particles and microorganisms in the nasal passages.
  4. 4

    Mouth

    • Lysozyme in saliva. The same bacteria-destroying enzyme. Saliva also continuously lubricates and cleanses the oral cavity.
    • Mucin in saliva. The mucin in watery saliva traps microorganisms and washes them out of the mouth into the stomach, where they are digested.
  5. 5

    Airway

    • Mucus (mucin). Mucin dissolved in water forms thick, sticky mucus. It lines the respiratory and digestive passageways and traps many microorganisms.
    • Cilia. Another structural modification of the respiratory mucosa. Cilia on the mucosa of the upper respiratory tract sweep dust- and bacteria-laden mucus toward the mouth, propelling it away from the nasal cavity and keeping it out of the lower respiratory passages. The respiratory tract features a mucociliary escalator.
    • Lysozyme in respiratory mucus. Hydrolyzes the peptidoglycan cell wall of bacteria.
  6. 6

    Stomach

    • Acid. Gastric juice contains concentrated hydrochloric acid. Stomach secretions are part of the acid mantle, which inhibits bacterial growth.
    • Pepsin. Pepsin from the gastric mucosa digests pathogen proteins. The stomach's protein-digesting enzymes kill many different microorganisms.
  7. 7

    Urinary and reproductive tracts

    • Acid mantle of the vagina. Acidic vaginal secretions inhibit the growth of most bacteria and fungi in the female reproductive tract.
    • Urine. Its normally acid pH inhibits bacterial growth, and it cleanses the lower urinary tract as it flushes from the body.

Mucus is listed both ways: slide 4 calls it a physical barrier, while slide 12 and the textbook list mucin with the protective chemicals.

When the wall is breached: the surface barriers are quite effective, but everyday nicks and cuts break them, for example when you brush your teeth or shave. Microorganisms then invade deeper tissues, and that triggers the internal second line of defense, which protects the deeper tissues.

Line 2 · Spotting the invader

21.2 How the second line recognizes an invader

TLRmicrobial structurealarm
Line 2 · Phagocytosis

21.2 How a phagocyte eats a pathogen

Phagocytes (phago = eat) are central to innate defense. They are white blood cells that ingest and digest intruders. Pathogens that get through the skin or mucosae into the underlying connective tissue are confronted by them.

Pathogen Phagocyte Lysosome
pathogenphagocyte 1ADHERE

The phagocyte uses receptors to recognize and adhere to the carbohydrate "signature" of a pathogen (or to debris). It must adhere before it can ingest.

pseudopodia 2ENGULF

The phagocyte engulfs the particle much the way an amoeba ingests a food particle. Receptors on its flowing cytoplasmic extensions (pseudopodia, or pseudopods) bind to the particle. The particle is then pulled inside, enclosed within a membrane-lined vesicle called a phagosome (phagocytic vesicle).

phagosomelysosome 3FUSE

The phagosome fuses with a lysosome, which carries acid hydrolase enzymes. Together they form a phagolysosome.

phagolysosome 4DIGEST

Neutrophils and macrophages generally kill their prey by acidifying the phagolysosome and digesting its contents with lysosomal enzymes. Toxic compounds and lysosomal enzymes destroy the pathogen.

waste 5EXPEL

Indigestible and residual material is sometimes removed by exocytosis.

Line 2 · When phagocytosis fails

Three ways it goes wrong, and the body's answer to each

The problem The body's answer Chemical signals and helpers
capsule
Problem · step 1

The phagocyte cannot grab on

Phagocytic attempts are not always successful. To ingest a pathogen, the phagocyte must first adhere to it by recognizing certain carbohydrates on its surface. Many bacteria have an external capsule that conceals this carbohydrate signature and makes them too slippery to bind, so they elude capture.

opsonins
Answer · opsonization

Coat it with handles

Opsonins (antibodies or complement proteins) coat the pathogen and give the phagocyte's receptors "handles" to bind, making it more adhesive. Any pathogen can be coated. The process is called opsonization ("to make tasty"), and it greatly accelerates phagocytosis.

alive
Problem

The pathogen survives being eaten

Some pathogens, such as the tuberculosis bacillus (Mycobacterium tuberculosis) and certain parasites, are resistant to the acidified lysosomal enzymes. They are not killed and can even multiply inside the phagolysosome.

burst Thelper
Answer · Plan B: respiratory burst

Call a helper T cell

Helper T cells release chemicals that stimulate the macrophage. This activates additional enzymes that produce a lethal respiratory burst: the secretion of cell-killing chemicals. It kills by:

  • liberating a deluge of highly destructive free radicals, such as superoxide
  • producing oxidizing chemicals: hydrogen peroxide (H2O2) and a substance identical to household bleach
  • increasing the phagolysosome's pH and osmolarity, which activates other protein-digesting enzymes (proteases) that digest the invader

Normal digestion acidifies the phagolysosome. The burst then raises its pH.

not ingested
Problem

The target cannot be ingested

Sometimes phagocytes are unable to ingest their targets.

neutrophilnet
Answer · attack from outside

Release the weapons outside the cell

The phagocytes secrete hydrolytic enzymes and other toxic chemicals into the extracellular fluid instead.

  • Neutrophils undergo netosis. They release a sticky net made of their own DNA and proteins that traps and kills extracellular pathogens.
  • Eosinophils destroy parasitic worms with a mix of toxic chemicals, and release chemokines to recruit help.
  • Basophils secrete histamine against allergens. They also secrete DNA and protein to create basophil extracellular traps (BETs), which trap and kill bacteria and parasites.

Whether they kill ingested or extracellular targets, neutrophils rapidly destroy themselves in the process. Macrophages are more robust and survive to kill another day.

Neutrophils also use defensins to kill by piercing the pathogen's membrane.

Line 2 · The phagocytes

The phagocytes

1st

Neutrophil

  • The most abundant type of white blood cell.
  • First to respond to bacterial infection.
  • Becomes phagocytic on exposure to infectious material in the tissues.
  • Dies in the course of phagocytizing bacteria.

Macrophage

  • "Big eaters": the most voracious phagocytes.
  • Ravenous, robust and non-specific. Survives to kill another day.
  • Develops from a monocyte, a white blood cell that leaves the blood, enters the tissues and becomes a macrophage.
  • Free macrophages travel through blood and wander through the tissue spaces in search of cellular debris or foreign invaders. Example: alveolar macrophages exit the pulmonary capillaries to patrol the lungs.
  • Fixed macrophages are permanent residents of a given organ: stellate macrophages (liver), microglia (brain), alveolar macrophages (lungs).
T antigenlymph node

Dendritic cell

  • Patrols the periphery: skin and mucous membranes.
  • Ingests antigen, enters the lymphatics and carries the antigen back to a lymph node.
  • Presents the antigen to a T cell to activate it.
Slides and textbook differ

Slides: macrophages develop from monocytes.

Textbook: only free macrophages do. Fixed macrophages are not derived from monocytes. They arise early in embryonic development, from a structure called the yolk sac.

Also: the slides list alveolar macrophages under both free and fixed macrophages. The textbook names stellate macrophages in the liver as its example of fixed macrophages.

Line 2 · Natural killer cells

21.2 Natural killer (NK) cells: checking cells for "self"

NK 1PATROL

NK cells "police" the body in blood and lymph.

MHC 2CHECK

A cell's "self" surface proteins (class I MHC) inhibit NK cell attack.

no MHC 3KILL

A cell that lacks them is contacted directly and made to undergo apoptosis.

The details

  • NK cells are a unique group of defensive cells that can kill cancer cells and virus-infected body cells before the adaptive immune system is activated.
  • They are nonphagocytic, large granular lymphocytes (part of a small group of large granular lymphocytes).
  • Lymphocytes of the adaptive system only recognize and react against specific infected or tumor cells. NK cells are far less picky. The name "natural" reflects this nonspecificity.
  • They detect general abnormalities rather than specific antigens, such as the lack of "self" cell-surface proteins called MHC. Your slides: they attack cells that lack "self" cell-surface receptors such as MHC proteins.
  • They are not phagocytic. They kill by directly contacting the target cell and inducing it to undergo apoptosis (programmed cell death, or cell suicide). This is the same method cytotoxic T cells use.
  • They also secrete potent chemicals that enhance the inflammatory response. So the two primary effects of NK cells are: induce apoptosis, and secrete inflammatory chemicals.
Line 2 · Inflammation

21.2 Inflammation: the tissue's response to injury

Three stages, in order.

mast cellhistamine 1ALARM

Inflammatory chemicals are released into the extracellular fluid.

arteriole dilates capillary leaks exudate 2VESSELS

Arterioles dilate and capillaries become leaky.

neutrophilscapillary 3PHAGOCYTES

Phagocytes are mobilized: neutrophils first, macrophages follow.

How one injury produces the four signs

Initial stimulus Physiological response Sign of inflammation Result
Tissue injury
↓ two things are released ↓
Inflammatory chemicals
histamine, complement, kinins, prostaglandins, etc.
Leukocytosis-inducing factors
↓
From the chemicals
Arterioles dilate
↓
Local hyperemia
(increased blood flow to the area)
↓
Heat
Redness
↓ from heat
Locally increased temperature increases the metabolic rate of cells
From the chemicals
Capillary permeability increases
↓
Capillaries leak fluid: exudate forms
↓
Leaked protein-rich fluid in the tissue spaces
↓
Swelling
↓
Pain
The chemicals also cause pain directly
↓
Possible temporary impairment of function
From the leaked fluid
Leaked clotting proteins form interstitial clots that wall off the area, to prevent movement of the pathogen to surrounding tissue
↓
A temporary fibrin patch forms scaffolding for repair
From the leukocytosis-inducing factors
Leukocytosis
(increased numbers of white blood cells in the bloodstream)
↓
Leukocytes migrate to the injured area. The chemicals attract neutrophils, monocytes and lymphocytes (chemotaxis)
↓ also from the chemicals
Margination
(leukocytes cling to capillary walls)
↓
Diapedesis
(leukocytes pass through capillary walls)
↓
Phagocytosis of pathogens and dead tissue cells. Pus may form.
↓
Area cleared of debris
↓ every branch leads to ↓
Healing

What inflammation is and why it helps

  • Inflammation is a nonspecific response to any tissue injury. Causes: physical trauma, intense heat, irritating chemicals, or infection.
  • Four benefits: it prevents the spread of damaging agents to nearby tissues, disposes of cell debris and pathogens, alerts the adaptive immune system, and sets the stage for repair.
  • Four cardinal signs (distinguishing indicators) of acute (short-term) inflammation: redness, heat, swelling and pain (inflam = set on fire). Some consider impaired function a fifth sign, seen if movement or use of the area is hampered. Example: an inflamed joint is hard to move, which forces it to rest and aids healing.
  • Many inflammations have specific names: the organ or tissue affected plus -itis (tonsillitis, appendicitis, tendonitis).
  • The second line's hallmark is inflammation. It enlists macrophages, mast cells, all types of white blood cells, and dozens of chemicals.

Stage 1 · Inflammatory chemical release

  • The process begins with a chemical "alarm": a flood of inflammatory chemicals released into the extracellular fluid by injured or stressed tissue cells and by immune cells. Your slides: damaged tissue and white blood cells release fluid into the ISS (interstitial space).
  • Mast cells are a key component and release the potent chemical histamine. Other inflammatory mediators include kinins, prostaglandins (PGs), cytokines and, if pathogens are involved, complement. Inflammatory chemicals can also be formed from chemicals circulating in the blood.
  • What they all do: dilate local arterioles and make local capillaries leakier. Many also attract phagocytes to the area (your slides: many secrete chemokines to attract phagocytes). Some have individual roles, such as mobilizing lymphocytes and other elements of adaptive immunity.

Histamine

Source
Granules of mast cells and basophils. Released in response to mechanical injury, the presence of certain microorganisms, and chemicals released by neutrophils.
Effects
Promotes vasodilation of local arterioles, increasing blood flow to the injured area. Increases permeability of local capillaries, promoting formation of exudate.

Kinins (bradykinin and others)

Source
A plasma protein, kininogen, is split by the enzyme kallikrein (found in plasma, urine, saliva, and in lysosomes of neutrophils and other cells). Splitting releases active kinin peptides. Your slides: kinins come from hepatocytes.
Effects
Same as histamine. Also induce chemotaxis of leukocytes and prompt neutrophils to release lysosomal enzymes, which generates more kinins. Induce pain.

Prostaglandins (PGs)

Source
Fatty acid molecules produced from arachidonic acid, found in all cell membranes. Generated by enzymes of neutrophils, basophils, mast cells and others. Your slides: from white blood cells and all body cells.
Effects
Same as histamine. Also induce neutrophil chemotaxis. Induce pain. Some prostaglandins are anti-inflammatory.

Complement

Source
A group of plasma proteins, activated to form potent inflammatory chemicals if pathogens provoked the inflammation. Your slides: from hepatocytes.
Effects
See the Complement section.

Cytokines

Source
Your slides: from WBCs, "endos" and "fibros".
Effects
A group of chemical mediators of immune responses, covered later in the chapter.

Stage 2 · Vasodilation and increased vascular permeability

  • Vasodilation of local arterioles causes local hyperemia: the tissue becomes engorged with blood. Hyperemia delivers more cells and chemicals of the immune system, and it accounts for the redness and heat.
  • Increased permeability of local capillaries and venules lets exudate (fluid containing clotting factors and antibodies) seep from the blood into the tissue spaces. This causes local swelling (edema).
  • Pain: the swelling presses on adjacent nerve endings. Pain also results from bacterial toxins and from the sensitizing effects of prostaglandins and kinins. Aspirin and some other anti-inflammatory drugs reduce pain by inhibiting prostaglandin synthesis.
  • Why edema helps: the surge of protein-rich fluid sweeps foreign material into the lymphatic vessels for processing in the lymph nodes. It also delivers clotting proteins and complement to the interstitial fluid.
  • The clotting factors form a gel-like fibrin mesh (a clot). It acts as a scaffold for permanent repair, and it isolates the injured area so bacteria and other harmful agents cannot spread.
  • Walling off is so important that some bacteria (such as Streptococcus) have evolved enzymes that break down the clot, letting them invade surrounding tissues.

Stage 3 · Phagocyte mobilization

  • Soon after inflammation begins, phagocytes flood the damaged area. Neutrophils lead, followed by monocytes (which become macrophages). The four steps are in the next section.
  • If the inflammation is caused by pathogens, complement is activated and adaptive immunity is recruited.
Line 2 · Phagocyte mobilization

21.2 How phagocytes get from the bone marrow to the wound

marrowblood 1LEUKOCYTOSIS

Injured cells release leukocytosis-inducing factors. Neutrophils enter the blood from red bone marrow, and within a few hours the blood neutrophil count rises four- to fivefold (your slides: 5x in hours). This increase in white blood cells is characteristic of inflammation.

CAMs 2MARGINATION

Phagocytes cling to the inner walls (margins) of the capillaries and postcapillary venules. Inflamed endothelial cells sprout cell adhesion molecules (CAMs) into the vessel lumen that signal "this is the place". Neutrophils bind them briefly, which makes them slow and roll along the wall while inflammatory chemicals activate them. Activated neutrophils sprout their own CAMs and bind the endothelial cells tightly, getting an initial foothold.

3DIAPEDESIS

Under continued chemical signaling, neutrophils flatten and squeeze between the endothelial cells of the capillary walls, moving out into the interstitial spaces. The capillary wall is the endothelium plus its basement membrane.

chemical trail 4CHEMOTAXIS

Inflammatory chemicals diffusing from the inflamed site act as homing devices, or chemotactic agents. Neutrophils and, later, other white blood cells undergo positive chemotaxis: they migrate up the gradient to the site of injury.

What happens after they arrive

  • Within an hour after the inflammatory response begins, neutrophils have collected at the site and are devouring any foreign material present.
  • As the counterattack continues, monocytes follow. Monocytes are fairly poor phagocytes, but within 12 hours of leaving the blood and entering the tissues (your slides: 12 hours after leaving the bloodstream) they swell, develop large numbers of lysosomes, and become macrophages with insatiable appetites.
  • These "late-arrivers" replace the dying neutrophils and continue with debris removal before repair.
  • Macrophages are the central actors in the final disposal of cell debris as acute inflammation subsides, and they predominate at sites of chronic inflammation.
  • The ultimate goal is to clear the injured area of pathogens, dead tissue cells and other debris so the tissue can be repaired. Once that is done, healing usually occurs quickly.

Homeostatic Imbalance 21.1: when the battle is severe

Pus

  • In severely infected areas the battle takes a toll on both sides. Creamy yellow pus may accumulate in the wound: a mixture of dead or dying neutrophils, broken-down tissue cells, and living and dead pathogens.
collagen wall

Abscess

  • If the inflammatory mechanism fails to clear the area of debris, collagen fibers may be laid down. They wall off the sac of pus, forming an abscess. It may need to be surgically drained before healing can occur.

Granuloma

  • Some bacteria, such as tuberculosis bacilli, resist digestion by the macrophages that engulf them. Snug inside their macrophage hosts, they also escape prescription antibiotics.
  • A granuloma forms: a tumorlike growth with a central region of infected macrophages, surrounded by uninfected macrophages and an outer fibrous capsule.
  • A person may harbor pathogens walled off in granulomas for years without symptoms. The bacteria may remain inactive forever, but if the person's resistance to infection is ever compromised, they may be activated, break free and cause disease.
Line 2 · Antimicrobial proteins · Interferons

21.2 Interferons: an infected cell warns its neighbors

Virus Interferon Antiviral proteins
1 2 3 4 5 host cell 1host cell 2
  1. 1

    Virus enters the cell and replicates. The viral nucleic acid gets in and new viruses are made. Host cell 1 is infected by the virus.

  2. 2

    Interferon genes switch on in the DNA of the infected cell's nucleus, and mRNA for interferon is made.

  3. 3

    The cell produces interferon molecules and releases them. Host cell 1 makes interferon but is killed by the virus.

  4. 4

    Interferon binds a receptor on host cell 2 and stimulates it to turn on genes for antiviral proteins. Antiviral mRNA is made.

  5. 5

    Antiviral proteins block viral reproduction. Interferon has induced host cell 2 to synthesize these protective proteins.

The details

  • Antimicrobial proteins enhance innate defense by attacking microorganisms directly or by hindering their ability to reproduce. The most important are interferons and complement proteins.
  • Viruses are essentially nucleic acids surrounded by a protein envelope. They lack the cellular machinery to generate ATP or synthesize proteins, so they invade tissue cells and take over the cell's metabolic machinery to reproduce themselves.
  • Infected cells can do little to save themselves, but some can secrete small proteins called interferons (IFNs) to "warn" neighbors and help protect cells that have not yet been infected.
  • IFNs diffuse to nearby cells and bind receptors on them. This stimulates the cells to synthesize proteins that block further protein synthesis and degrade viral RNA. In this way they "interfere" with viral replication. Your slides: the genes switched on encode proteins that block viral entry, replication and assembly.
  • IFN protection is not virus-specific, so IFNs produced against one virus protect against other viruses too.
  • Interferons are a family of immune-stimulating (immune modulating) proteins produced by a variety of body cells, each with a slightly different effect.
  • IFN alpha (α) and beta (β) have the antiviral effects above and also activate NK cells.
  • IFN gamma (γ), or immune interferon, is secreted by lymphocytes. It has widespread immune mobilizing effects and activates NK cells and macrophages.
  • Macrophages and NK cells can act directly against cancerous cells, so interferons have an indirect role in fighting cancer.
  • Artificial IFNs are used to treat disorders such as cancer, hepatitis C, genital warts and multiple sclerosis.
  • In summary: proteins released by virus-infected cells and certain lymphocytes that act as chemical messengers to protect uninfected tissue cells from viral takeover, and that mobilize the immune system.
Line 2 · Antimicrobial proteins · Complement

21.2 Complement: three ways in, one split, three outcomes

Classical pathway
Activated by antibodies coating the target cell
Lectin pathway
Activated by lectins binding to specific sugars on the microorganism's surface
Alternative pathway
Activated spontaneously. Lack of inhibitors on the microorganism's surface lets it proceed
↓ all three converge ↓
C3
split into two active pieces: C3a and C3b
↓
C3b → Opsonization
Coats pathogen surfaces, which enhances phagocytosis
C3b → MAC → Cell lysis
C3b triggers insertion of C5b–C9, the membrane attack complex. Its pore lets water rush in
C3a C5a histamine mast cell C5a C3a, C5a → Inflammation
Stimulates histamine release, increases blood vessel permeability, attracts phagocytes by chemotaxis, etc.

What complement is

  • The complement system, or complement, is a group of at least 20 plasma proteins (your slides: about 20 inactive blood proteins) that normally circulate in the blood in an inactive state. It includes proteins C1 through C9, factors B, D and P, and regulatory proteins.
  • It provides a major mechanism for destroying foreign substances such as bacteria and mismatched red blood cells.
  • Three things it does: enhances inflammation, enhances opsonization, and lyses (bursts open) pathogens directly. Its activation unleashes inflammatory chemicals that amplify virtually all aspects of the inflammatory process. Activated complement kills certain bacteria and other cell types.
  • Our own cells are equipped with proteins that normally inhibit complement activation.
  • Complement is nonspecific, but it "complements" (enhances) the effectiveness of both innate and adaptive defenses.

The three activation pathways

  • Classical pathway. Involves antibodies, the water-soluble proteins the adaptive immune system produces. Antibodies bind antigen on the pathogen, and the antigen-bound antibody's stem then binds complement and activates it. This double binding is called complement fixation, and it is the first step of the pathway. Complement activation yields C3.
  • Lectin pathway. Lectins are water-soluble proteins the innate system produces to recognize foreign invaders. A lectin binds specific sugars on the pathogen's surface, and the pathogen-bound lectin then binds and activates complement (your slides: binds and activates C3).
  • Alternative pathway. Spontaneously activated C3 interacts with other complement factors (B, D and P) on the pathogen's surface. Microorganisms lack the inhibitors of complement activation that our own cells have, so the process proceeds.
  • Like the blood clotting cascade, each pathway activates proteins in an orderly, predictable sequence, each step catalyzing the next.
  • All three pathways converge at C3 (which acts together with other complement proteins and factors), and it is cleaved into C3a and C3b. Splitting C3 initiates the final common (terminal) pathway, which enhances inflammation, promotes phagocytosis and can cause cell lysis.

The three outcomes

  • Opsonization. C3b molecules act as opsonins. They coat the microorganism and provide "handles" that receptors on macrophages and neutrophils can adhere to, so they engulf the particle more rapidly.
  • Cell lysis. C3b binds to the target cell's surface and triggers the insertion of complement proteins C5b through C9, the membrane attack complex (MAC), into the cell's membrane. MAC forms and stabilizes a pore that lets water rush in and cell contents leave, lysing the cell. MACs form only on the surfaces of certain target cells, usually bacteria.
  • Inflammation. C3a and other cleavage products amplify inflammation. C3a and C5a stimulate mast cells and basophils to release histamine. C5a attracts neutrophils, macrophages and other white blood cells.
Line 2 · Fever

21.2 Fever: resetting the body's thermostat

1EXPOSURE

White blood cells and macrophages are exposed to foreign substances in the body.

pyrogens 2PYROGENS

They secrete chemicals called pyrogens (pyro = fire).

hypothalamus 3SET POINT UP

Pyrogens act on the body's thermostat, a cluster of neurons in the hypothalamus, and raise its set point.

4HEAT UP

The hypothalamus activates its heat-promotion center, which acts through the SNS: skin blood vessels constrict, shivering begins, and BMR rises. Body temperature climbs.

The details

  • Fever is an abnormally high body temperature. It is a systemic response to invading microorganisms. Inflammation, by contrast, is a localized response to infection.
  • Pyrogens raise body temperature above normal, which is 37°C (98.6°F).
  • The hypothalamus raises temperature by activating the heat-promotion center, which acts through the SNS: cutaneous vasoconstriction, shivering, and increased BMR.
  • We are just beginning to understand how fever benefits the body.

Benefits of moderate fever

  • The liver and spleen sequester iron and zinc. This makes it harder for bacteria to obtain these metal ions, which impedes pathogen replication and suppresses bacterial growth.
  • It increases the metabolic rate of tissue cells, which accelerates tissue repair.
  • Recent findings show it increases the migration of T lymphocytes and monocytes into lymph nodes, which enhances the immune response. It also increases the rate of T lymphocyte production.
  • In summary: a systemic response initiated by pyrogens. High body temperature inhibits microbes from multiplying and enhances body repair processes.
Line 2 · At a glance

The second line of defense: innate cellular and chemical defenses

Line 3 · Adaptive defenses

Adaptive defenses: the soldiers have to meet the enemy first

antigen first meeting FIRST EXPOSURE

The adaptive system must "meet" a specific foreign substance (antigen). That is, it must be primed by an initial exposure to it.

time PRIMING TAKES TIME

This priming takes precious time. It is the adaptive system's shortcoming: the innate system is always ready and able to react.

later: quicker, stronger THEN IT PROTECTS

Only then can it protect the body against that substance. It has memory: a "known" antigen gets a quicker, stronger attack on subsequent exposures.

What the adaptive system is

  • The adaptive immune system is the body's built-in specific defense system. It targets and eliminates, with nearly equal precision, almost any type of pathogen that intrudes into the body (your slides: almost any pathogen or abnormal cell).
  • It is the body's third line of defense, like the soldiers of the medieval castle.
  • It recognizes something as foreign and acts to immobilize, neutralize, or remove it.
  • When it operates effectively, it protects us from a wide variety of infectious agents, as well as from abnormal body cells. When it fails, or is disabled, devastating diseases such as cancer and AIDS result.
  • Its activities: tremendously amplifies the inflammatory response, activates complement (it is responsible for most complement activation), destroys cells directly, and retains memory of previously encountered intruders.
  • Shortcoming: it must be primed by an initial exposure to a specific foreign substance (antigen), and priming takes time. At first glance this seems a major shortcoming, because the innate system is always ready and able to react.

Adaptive versus innate

Adaptive defenses
Innate defenses
Involve B and T lymphocytes
Involve diverse cells, processes and structures (for example NK cells, phagocytes, antimicrobial proteins, inflammatory chemicals and physical barriers)
Are specific: recognize and target antigens (identified pathogens or foreign substances)
Are nonspecific: like "guards", they check identification to see whether friend or foe
Slow to mobilize
Fast; always ready
Have memory: react even more strongly to successive encounters with the same antigen
Usually no memory
Are systemic (bodywide): not restricted to the initial infection site
Largely restricted to the site of initial infection (except fever)
  • Your slides list three characteristics of adaptive immunity. It is specific: recognizes and targets specific antigens. It is systemic: not restricted to the initial site. It has memory: mounts a quicker, stronger attack to "known" antigens upon subsequent exposures.
  • The textbook's table counts five key characteristics that differentiate adaptive responses from innate defenses: the five rows above.
  • The textbook's chapter summary names four: the adaptive immune response involves B and T lymphocytes, is antigen-specific, is systemic, and has memory.

The two arms of adaptive immunity

Adaptive immunity
two separate but overlapping arms (two main branches)
↓
B Humoral immunity
also called antibody-mediated immunity
Protection: antibodies, free in the body's fluids
Targets: extracellular
T Cellular immunity
also called cell-mediated immunity
Protection: living cells, the lymphocytes themselves
Targets: cellular

Humoral (antibody-mediated) immunity

  • Provided by antibodies present in the body's "humors", or fluids (blood, lymph, etc.). Your slides: it is called humoral because soluble proteins, antibodies, in the plasma provide the protection.
  • Antibodies are produced by lymphocytes (your slides: by B lymphocytes, Bs), but they circulate freely in body fluids (the blood and lymph).
  • They bind primarily to extracellular targets: bacteria, bacterial toxins and free viruses. They bind the target temporarily, which inactivates it temporarily and marks it for destruction by phagocytes or complement.

Cellular (cell-mediated) immunity

  • When lymphocytes rather than antibodies defend the body, the immunity is called cellular or cell-mediated, because living cells (the lymphocytes themselves; your slides: T lymphocytes, Ts) provide the protection.
  • It has cellular targets: cells infected with pathogens (such as viruses, some bacteria and parasites), cancer cells, and cells of foreign grafts. Your slides: Ts act against infected or damaged self cells.
  • Lymphocytes act against these targets directly, by killing the infected cells, or indirectly, by releasing chemicals.
  • Those chemicals enhance the inflammatory response, activate macrophages (your slides: activate other lymphocytes or macrophages), or even direct the entire adaptive immune response.
  • Many lymphocytes that belong to the cellular immunity branch act to coordinate both humoral and cellular adaptive immunity.

How the two arms were found

antibodies protected 1LATE 1800s

Animals that survived a serious bacterial infection had protective factors in their blood (the proteins we now call antibodies) that defend against future attacks by the same pathogen. When antibody-containing serum from the survivors was injected into animals never exposed to the pathogen, those animals were protected too.

not always lymphocytes 2MID-1900s

At first antibodies were thought to be the sole artillery of the adaptive immune system. Then researchers found that injecting antibody-containing serum did not always protect the recipient from diseases the serum donor had survived. In such cases, injecting the donor's lymphocytes did provide immunity.

What the experiments showed

  • The late-1800s experiments revealed the basis of this specific immunity.
  • As the pieces fell into place, researchers recognized two separate but overlapping arms of adaptive immunity, each using a variety of attack mechanisms that vary with the intruder: humoral and cellular.
Line 3 · 21.3 Antigens

21.3 Antigens: the substances that trigger the adaptive defenses

Antigen (nonself) Lymphocytes and antibodies The body's own protein

A complete antigen has two properties

Immunogenicity

  • The ability to stimulate specific lymphocytes to proliferate (multiply).

Reactivity

  • The ability to react with the activated lymphocytes and the antibodies released by immunogenic reactions.

What an antigen is

  • Antigens are substances that can mobilize the adaptive defenses. They are the ultimate targets of all adaptive immune responses.
  • "Antigen" is a contraction of "antibody generating".
  • Most antigens are large, complex molecules (natural or synthetic) that are foreign: not normally present in the body. So as far as our immune system is concerned, they are intruders, or nonself.
  • Characteristics of antigens: they contain antigenic determinants, and they can be a complete antigen or a hapten (incomplete antigen).

Complete antigens

  • Antigens can be complete or incomplete. Complete antigens have two important functional properties: immunogenicity and reactivity.
  • An almost limitless variety of foreign molecules can act as complete antigens, including virtually all foreign proteins, many large polysaccharides, and some lipids and nucleic acids. Of these, proteins are the strongest antigens.
  • Pollen grains and microorganisms, such as bacteria, fungi and virus particles, are all immunogenic because their surfaces bear many different foreign macromolecules.
  • Your slides: complete antigens are found on foreign invaders such as pathogens and allergens.

A hapten is an incomplete antigen

hapten 1ALONE

As a rule, small molecules are not immunogenic. They are too small and simple to be immunogenic by themselves.

body protein hapten 2LINKS UP

The small molecule links up with one of the body's own proteins (a protein carrier).

seen as foreign 3ATTACK

The adaptive immune system may recognize the combination as foreign and mount an attack that is harmful rather than protective. The immune system attacks the hapten-bearing self-proteins.

Slides and textbook differ

Slides (the haptens slide): by itself, a hapten is immunogenic but not reactive. Combined with a protein, it becomes reactive.

Textbook: unless attached to protein carriers, haptens have reactivity but not immunogenicity. They must combine with a body protein before becoming immunogenic. The slide before it also says haptens are too small and simple to be immunogenic by themselves.

Haptens

  • Incomplete antigens, also known as haptens, are molecules too small and simple to be immunogenic by themselves. Examples of such small molecules: peptides (your slides: small peptides), nucleotides, and many hormones (your slides: some hormones).
  • Haptein = "to grasp".
  • Haptens must bind a larger molecule to be antigenic.
  • If they link up with the body's own proteins, the adaptive immune system may recognize the combination as foreign and mount an attack that is harmful rather than protective. In such cases the troublesome small molecule is called a hapten, or incomplete antigen. Your slides: the combination is recognized and responded against by our immune system, which attacks hapten-bearing self-proteins.
  • These harmful reactions are called hypersensitivities.
  • Where haptens are found: certain drugs (particularly penicillin), and chemicals in poison ivy, animal dander, detergents, cosmetics, and a number of common household and industrial products.
Line 3 · 21.3 Antigenic determinants

21.3 Antigenic determinants: the parts of an antigen that get bound

Antigen and its determinants Antibodies
antigen antigenic determinant antigen-binding sites antibody A antibody B antibody C

Most antigens have several different antigenic determinants. Here three different types of antibodies react with different antigenic determinants on the same antigen molecule.

The details

  • The ability of a molecule to act as an antigen depends on both its size and its complexity.
  • Antigens are large, complex molecules, and only certain parts of the antigen are immunogenic. These parts are the antigenic determinants.
  • Antigenic determinants are the specific components of an antigen that antibodies or lymphocyte receptors bind to (your slides: antibodies and T cell receptors bind these parts). They are small areas on the antigen surface. The parts of the antibody that bind them are its antigen-binding sites.
  • The binding happens in much the same manner that an enzyme binds to a substrate.
  • Most naturally occurring antigens have a variety of antigenic determinants on their surfaces, some more potent than others in provoking an immune response.
  • Different lymphocytes "recognize" different antigenic determinants. So a single antigen may mobilize several lymphocyte populations and stimulate the formation of many kinds of antibodies.
  • In summary: antigenic determinants are the portions of antigen molecules that are recognized as foreign. Most antigens have many such sites.

Why size alone is not enough

Large protein

  • Has hundreds of chemically different antigenic determinants. That accounts for its high immunogenicity and reactivity.

Large simple molecule (plastic)

  • Has many identical, regularly repeating units, so it has little or no immunogenicity.
  • Such substances are used to make artificial implants, because they are not seen as foreign and rejected by the body.
Line 3 · 21.3 Self-antigens

21.3 Self-antigens: MHC proteins mark your cells as "self"

your cell your lymphocyte IN YOU

A huge variety of protein molecules dot the external surfaces of all your cells. Your self-antigens are not foreign or antigenic to you.

your cell other person'slymphocyte strongly antigenic IN SOMEONE ELSE

The same self-antigens are strongly antigenic to other individuals. This is the basis of transfusion reactions and graft rejection.

self foreign MHC THE GROOVE

Each MHC protein has a deep groove that holds a peptide: either a self-antigen or a foreign antigen.

T T CELLS

T lymphocytes can only bind antigens that are presented (displayed to them) on MHC proteins.

Self-antigens

  • A huge variety of protein molecules dot the external surfaces of all our cells.
  • Assuming your immune system has been properly "programmed", your self-antigens are not foreign or antigenic to you, but they are strongly antigenic to other individuals. This is the basis of transfusion reactions and graft rejection. Your slides: they may be antigenic to others in transfusions or grafts.

MHC proteins

  • Among the cell surface proteins that identify a cell as self is a group of glycoproteins called MHC proteins, one set of important self-proteins.
  • Genes of the major histocompatibility complex (MHC) code for these proteins.
  • Millions of combinations of these genes are possible, so it is unlikely that any two people except identical twins have the same MHC proteins. Your slides: unique to each individual.
  • Each MHC protein has a deep groove that holds and displays a peptide, either a self-antigen or a foreign antigen.
  • T lymphocytes (Ts) can only bind antigens that are presented, meaning displayed to them, on MHC proteins.
  • In summary: MHC proteins are membrane-bound glycoproteins that mark our cells as "self".
Line 3 · 21.4 Lymphocytes

21.4 Lymphocytes: five steps from bone marrow to a fighting clone

The three crucial cell types of the adaptive system

Two distinct populations of lymphocytes, plus antigen-presenting cells.

B

B lymphocytes (B cells)

  • Oversee humoral immunity.
T

T lymphocytes (T cells)

  • Non-antibody-producing lymphocytes that constitute the cellular arm of adaptive immunity.

Antigen-presenting cells (APCs)

  • Do not respond to specific antigens as lymphocytes do. Instead, they play essential auxiliary roles in immunity.
  • T cells cannot recognize their antigens without APCs.

The life story B and T cells share

red bone marrow 1ORIGIN

Both B and T lymphocyte precursors originate in red bone marrow.

T B thymusbone marrow 2MATURATION

Precursors destined to become T cells migrate (in blood) to the thymus and mature there. B cells mature in the bone marrow. During maturation lymphocytes develop immunocompetence and self-tolerance.

naivelymph node 3SEEDING

Immunocompetent but still naive lymphocytes leave the thymus and bone marrow. They "seed" the secondary lymphoid organs and circulate through blood and lymph.

antigen 4ENCOUNTER

Antigen encounter and activation: when a lymphocyte's antigen receptors bind its antigen, that lymphocyte can be activated.

M effector cellsmemory 5PROLIFERATION

Proliferation and differentiation: activated lymphocytes proliferate (multiply) and then differentiate into effector cells and memory cells.

1 Origin

  • Despite their differences, B and T lymphocytes share a common pattern of development and common steps in their life cycles: five general steps.
  • Like all blood cells, lymphocytes originate in red bone marrow from hematopoietic stem cells.

2 Maturation

  • Lymphocytes are "educated" (go through a rigorous selection process) as they mature. Education selects for two attributes: immunocompetence and self-tolerance.
  • Immunocompetence. Each lymphocyte must become able (competent) to recognize its one specific antigen by binding to it. Your slides: lymphocytes must recognize their antigen and no other.
  • When B or T cells become immunocompetent, they display a unique type of receptor on their surface. These receptors (some 105 per cell) enable the lymphocyte to recognize and bind a specific antigen.
  • Once these receptors appear, the lymphocyte is committed to react to one (and only one) distinct antigenic determinant, because all of its antigen receptors are the same. Mature Bs and Ts display only one type of antigen receptor and so bind only one specific antigen.
  • The receptors on B cells are in fact membrane-bound antibodies. The receptors on T cells are not antibodies, but they are products of the same gene superfamily and have similar functions.
  • Self-tolerance. Each lymphocyte must be relatively unresponsive to self-antigens so that it does not attack the body's own cells.
  • Maturation is a two- to three-day process. It occurs in the red bone marrow for B cells and in the thymus for T cells.
  • The lymphoid organs where lymphocytes mature, the thymus and red bone marrow, are called primary lymphoid organs. All other lymphoid organs are secondary lymphoid organs.

3 Seeding secondary lymphoid organs and circulation

  • Immunocompetent B and T cells that have not yet been exposed to antigen are called naive.
  • Naive B cells and T cells are exported from the primary lymphoid organs to "seed" (colonize) the secondary lymphoid organs (lymph nodes, spleen, and so on), where they are likely to encounter antigens. This increases the chance of an encounter with antigen.
  • Lymphocytes, especially the T cells (which account for 65–85% of bloodborne lymphocytes), circulate continuously throughout the body.
  • Circulating greatly increases a lymphocyte's chance of coming into contact with antigens located in different parts of the body, as well as with other lymphocytes and antigen-presenting cells. For example, a T cell circulates through lymph and blood and back to a lymph node about once a day.
  • Lymphocyte circulation appears to be random, but lymphocyte movement into the tissues is highly specific. It is regulated by homing signals (cell adhesion molecules) displayed on vascular endothelial cells.

4 Antigen encounter and activation

  • An antigen encounter is sometimes called an antigen challenge.
  • The first encounter between an immunocompetent but naive lymphocyte and an invading antigen usually takes place in a lymph node or the spleen, but it may happen in any secondary lymphoid organ.
  • Immune cells in lymph nodes are in a strategic position to encounter a large variety of antigens, because lymphatic capillaries pick up proteins and pathogens from nearly all body tissues.
  • When an antigen binds to the particular lymphocyte that has a receptor for it, the antigen selects that lymphocyte for further development. This is called clonal selection.
  • If the proper signals are present, the selected lymphocyte will activate to complete its differentiation into an active cell.
  • Clonal selection of T cells requires an APC. Complete activation requires an additional step directed by helper T cells.

5 Proliferation and differentiation

  • Once selected and activated, the lymphocyte rapidly proliferates: it divides repeatedly to form an army of cells exactly like itself, with the same antigen specificity. This army of identical cells, all descended from the same ancestor cell, is called a clone.
  • Most members of the clone become effector cells, the cells that actually do the work of fighting infection.
  • A few members of the clone become memory cells, which are able to respond quickly after any subsequent encounter with the same antigen (your slides: more quickly and powerfully in future encounters).
  • B and T memory cells and effector T cells circulate continuously, on continuous patrol, in the blood and lymph and throughout the secondary lymphoid organs.
  • Effector B cells (plasma cells) remain in the marrow.

B and T lymphocytes side by side

B lymphocytes
T lymphocytes
Type of immune response: humoral
Type of immune response: cellular
Antibody secretion: yes
Antibody secretion: no
Primary targets: extracellular pathogens (for example bacteria, fungi, parasites, viruses in extracellular fluid; your slides: some viruses in extracellular fluid)
Primary targets: intracellular pathogens (for example virus-infected cells) and cancer cells. In addition, helper T cells coordinate both B and T lymphocyte responses
Site of origin: red bone marrow
Site of origin: red bone marrow
Site of maturation: red bone marrow
Site of maturation: thymus
Effector cells: plasma cells
Effector cells: cytotoxic T (TC) cells, helper T (TH) cells, regulatory T (TReg) cells
Memory cell formation: yes
Memory cell formation: yes

In summary

  • The two-fisted adaptive immune system uses lymphocytes, APCs and specific molecules to identify and destroy all substances, both living and nonliving, that are in the body but not recognized as self.
  • The system's response depends on the ability of its cells to (1) recognize antigens by binding to them and (2) communicate with one another, so that the whole system mounts a response specific to those antigens.
  • Interactions between various lymphocytes, and between lymphocytes and APCs, underlie virtually all phases of the adaptive immune response.
Line 3 · 21.4 Antigen receptor diversity

21.4 Antigen receptor diversity: a billion receptors from a small set of gene pieces

Gene segments
A lymphocyte stem cell holds a few hundred genetic bits and pieces: a "Lego set" for antigen receptor genes
↓
Somatic recombination
As each lymphocyte becomes immunocompetent, the gene segments are shuffled and combined in different ways
↓
Up to a billion different antigen receptors
The newly assembled genes are expressed as the surface receptors of B and T cells, and as the antibodies later released by a B cell's "offspring"
Slides and textbook differ

Slides: about 25,000 genes encode a billion different antigen receptors.

Textbook: each body cell contains only about 20,000 genes that code for all the proteins the cell must make.

Genes decide, antigens select

  • Lymphocytes become immunocompetent before meeting the antigens they may later attack.
  • Our genes, not the antigens we encounter, determine which specific foreign substances our immune system will be able to recognize and resist.
  • In other words, the immune cell receptors represent our genetically acquired knowledge of the microbes that are likely to be in our environment.
  • An antigen simply determines which existing T or B cells will proliferate and mount the attack against it.
  • Our genome has libraries of potential B and T cells that are activated upon first exposure to their specific antigen.
  • Only some of the antigens our lymphocytes are programmed to resist will ever invade our bodies. So only some members of our army of immunocompetent cells are mobilized in our lifetime. The others are forever idle.

How a limited number of genes makes so many receptors

  • Our lymphocytes make up to a billion different types of antigen receptors.
  • These receptors, like all other proteins, are specified by genes, so you might think an individual must have billions of genes. Not so.
  • The genes that dictate the structure of each antigen receptor are not present as such in lymphocyte stem cells. Instead of a complete set of "antigen receptor genes", stem cells contain a few hundred genetic bits and pieces that can be thought of as a "Lego set" for antigen receptor genes.
  • As each lymphocyte becomes immunocompetent, these gene segments are shuffled and combined in different ways. This process is called somatic recombination.
  • The information in the newly assembled genes is then expressed as the surface receptors of B and T cells and as the antibodies later released by a B cell's "offspring".
Line 3 · 21.4 Lymphocyte education

21.4 T cell education in the thymus: two tests, and most cells fail

antigen-presentingthymic cell developing T cell self-MHC self-antigen T cell receptor
Test 1: Positive selection
T cells must recognize self major histocompatibility proteins (self-MHC)
↓ fails
Apoptosis
Failure to recognize self-MHC results in apoptosis (programmed cell death, or death by cell suicide)
↓ passes
Survival
Recognizing self-MHC results in survival. Survivors proceed to negative selection
↓
Test 2: Negative selection
T cells must not recognize self-antigens
↓ fails
Apoptosis
Recognizing self-antigen results in apoptosis. This eliminates self-reactive T cells that could cause autoimmune diseases
↓ passes
Survival
Failure to recognize (bind tightly to) self-antigen results in survival and continued maturation

Positive selection

  • The selection process (education) that lymphocytes undergo during maturation is best understood in T cells. T cells mature in the thymus under positive and negative selection pressures ("tests").
  • Positive selection is the first of the two tests a developing T lymphocyte must pass. It ensures that only T cells with receptors able to recognize self-MHC proteins survive. Your slides add the label "MHC restriction" to this test.
  • Remember that T cells cannot bind antigens unless the antigens are presented on self-MHC proteins.
  • T cells that are unable to recognize self-MHC are eliminated by apoptosis.

Negative selection

  • Negative selection, the second test, ensures that T cells do not recognize self-antigens displayed on self-MHC. If they do, they are eliminated by apoptosis.
  • Negative selection is the basis for immunological self-tolerance. It makes sure that T cells do not attack the body's own cells, which would cause autoimmune disorders.
  • Because the self-reactive lymphocyte and all of its potential progeny are eliminated, this is called clonal deletion.

The cost, and B cells

  • This education of T cells is expensive: only about 2% of T cells survive it and continue to become successful immunocompetent, self-tolerant T cells.
  • Less is known about the factors that control B cell maturation. Like T cells, only immunocompetent B cells are allowed to mature.
  • Selection is not perfect for either B or T cells: some self-reactive lymphocytes survive.
Line 3 · 21.4 Antigen-presenting cells

21.4 Antigen-presenting cells: they show the antigen to the T cells

Phagocyte acting as APC B and T cells Antigen

How a dendritic cell delivers an antigen

skin 1CATCH

At the body's frontiers, dendritic cells internalize antigens by phagocytosis. Their long, wispy extensions make them very efficient antigen catchers.

lymphaticlymph node 2TRAVEL

They then enter nearby lymphatics to get to a lymph node.

T 3PRESENT

In the lymph node they present the antigens to T cells.

What APCs do

  • Antigen-presenting cells (APCs) engulf antigens and then present fragments of them (antigenic determinants), like signal flags, on their own surfaces where T cells can recognize them.
  • Naive T cells can only be activated by antigens that are presented to them on MHC proteins by APCs. In other words, APCs present antigens to the cells that will deal with the antigens.
  • The major types of cells acting as APCs are dendritic cells, macrophages and B lymphocytes.

The three APCs

Dendritic cells

  • Found at the body's frontiers (skin, for example), where they act as mobile sentinels of boundary tissues. Your slides: found in the epidermis of the cutaneous membrane, and in the epithelium and lamina propria of mucous membranes.
  • They phagocytize pathogens that enter the tissues, then enter the lymphatics to present the antigens to T cells in a lymph node.
  • Migration of dendritic cells to secondary lymphoid organs is now recognized as the most important way of ensuring that lymphocytes encounter invading antigens.
  • Dendritic cells are the most effective antigen presenter known. It is their only job.
  • This early alert spares the body a good deal of tissue damage that might otherwise occur.
  • They are one of the key links between innate and adaptive immunity. They initiate adaptive immune responses tailored to the type of pathogen they have encountered (your slides: tailored to the specific antigen).
T helper T IFN-γ, TNF-a

Macrophages

  • Widely distributed throughout the lymphoid organs and connective tissues.
  • Like dendritic cells, macrophages can activate naive T cells. But they often present antigens to T cells for other reasons: to maintain T cell activation, or to be activated themselves. Your slides list these as three reasons: activate naive T cells, sustain T activation, activate the macrophages themselves.
  • Certain effector T cells release chemicals that prod macrophages to become activated macrophages. Your slides: helper T cells (TH) secrete IFN-γ and TNF-a.
  • Activated macrophages are true "killers": insatiable phagocytes that also trigger powerful inflammatory responses and recruit additional defenses.
B T helper T

B lymphocytes

  • Unlike dendritic cells and macrophages, B cells do not activate naive T cells.
  • Instead, they present antigens to a certain kind of T cell, a helper T cell (TH), in order to obtain "help" in their own activation.
  • The helper T cell secretes IL-4 to co-stimulate the B cell's final activation.
Line 3 · 21.5 Humoral immune response

21.5 The humoral response: one B cell becomes a clone of plasma cells and memory cells

When a B cell encounters its antigen (its complementary antigen), that antigen provokes the humoral immune response, in which antibodies specific for that antigen are made.

B antigen 1CLONAL SELECTION

Antigen binds to a receptor on a specific B lymphocyte. B lymphocytes with noncomplementary receptors remain inactive.

clone 2aPROLIFERATION

The activated B cells proliferate to form a clone.

plasma cell 2bPLASMA CELLS

Most cells of the clone become plasma cells (effector B cells), which secrete antibody molecules.

M memory B cell 2cMEMORY CELLS

The other clone cells become memory B cells, primed to respond to the same antigen.

1 Clonal selection

  • An immunocompetent but naive B lymphocyte is activated when matching antigens bind to its surface receptors (membrane-bound antibodies on the B cell's membrane). This is clonal selection, step 1 of the humoral immune response.
  • Some antigens cross-link adjacent receptors together.
  • Antigen binding is quickly followed by receptor-mediated endocytosis (RME) of the antigen-receptor complexes: the B cell engulfs them.
  • The B cell hydrolyzes the antigen and presents its peptides on the B cell's MHC II to a helper T cell (TH) for co-stimulation.
  • Interactions with T cells are usually required to help B cells achieve full activation.

2 Proliferation and differentiation: plasma cells

  • Clonal selection is followed by proliferation and differentiation into effector cells. This is step 2 of the humoral immune response.
  • Most cells of the clone differentiate into plasma cells, the antibody-secreting effector cells of the humoral response.
  • Plasma cells develop the elaborate internal machinery (largely rough endoplasmic reticulum) needed to secrete antibodies at the unbelievable rate of about 2000 molecules per second. Each plasma cell functions at this breakneck pace for 4 to 5 days and then dies.
  • The secreted antibodies each have the same antigen-binding properties as the receptor molecules on the surface of the parent B cell. They circulate in the blood or lymph, where they bind to free antigens and mark them for destruction by other innate or adaptive mechanisms.

2 Proliferation and differentiation: memory cells

  • Clone cells that do not become plasma cells (a few clone cells) become long-lived memory cells.
  • They can mount an almost immediate humoral response if they encounter the same antigen again in the future.
  • Secondary response (can be years later): a subsequent challenge by the same antigen results in a larger, more rapid response. The memory B cell forms a clone of cells identical to the ancestral cells. The figure draws more plasma cells, more secreted antibody molecules and more memory B cells than in the primary response.
Line 3 · 21.5 Immunological memory

21.5 Immunological memory: the second response is faster and bigger

first exposure second exposure antibody titer time lag primary response secondary response 100 to 1000× higher

Primary versus secondary response

Primary immune response
Secondary immune response
On first exposure to a particular antigen
On reexposure to the same antigen, whether it is the second or the twenty-second time
Lag period of 3 to 6 days after the antigen encounter
Within hours a new army of plasma cells is being generated (responds within hours, not days)
Plasma antibody levels reach their peak in about 10 days
Antibody titer rises steeply and peaks within 2 to 3 days
Lower peak. Antibody levels then decline
Much higher levels than in the primary response. Blood levels remain high for weeks to months
Each plasma cell works for 4 to 5 days
With the appropriate chemical signals, plasma cells can keep functioning for much longer than 4 to 5 days
Sets up the pool of effector cells and generates memory cells
Antibodies bind with greater affinity (more tightly)

The primary response

  • The cellular proliferation and differentiation of B cells constitute the primary immune response, which occurs on first exposure to a particular antigen.
  • It typically has a lag period of 3 to 6 days after the antigen encounter. The lag mirrors the time required for the few B cells specific for that antigen to proliferate (about 12 generations) and for their offspring to differentiate into plasma cells.
  • After the mobilization period, plasma antibody levels rise, reach peak levels in about 10 days, and then decline.

The secondary response

  • If (and when) someone is reexposed to the same antigen, a secondary immune response occurs. Secondary responses are faster, more prolonged and more effective.
  • Why: the immune system has already been primed to the antigen, and sensitized memory cells are already "on alert". These memory cells provide immunological memory.
  • Within hours after recognizing the "old enemy" antigen, a new army of plasma cells is being generated. Within 2 to 3 days the antibody concentration in the plasma, called the antibody titer, rises steeply to reach much higher levels than in the primary response.
  • Your slides: peak levels are 100 to 1000 times higher, and near-peak levels hold for weeks rather than days.
  • Secondary response antibodies bind with greater affinity (more tightly), and their blood levels remain high for weeks to months. Plasma cells keep secreting for far longer than the 4 to 5 days seen in primary responses.
  • Memory cells persist for long periods, and many retain their capacity to produce powerful secondary humoral responses for life.
  • The textbook's graph plots antibody titer (antibody concentration in plasma, in arbitrary units) on a scale from 100 to 104 against time in days. The primary immune response to antigen A occurs after a delay. At the second exposure to antigen A (day 28 in the figure), the secondary immune response is faster and larger.
  • The primary response to one antigen generates the memory cells that give rise to the enhanced secondary response to that same antigen. The response to a different antigen is independent: a first exposure to antigen B gives an ordinary primary response even while the response to antigen A is secondary.
  • The same general events occur in the cellular immune response: a primary response sets up a pool of effector cells (in this case T cells) and generates memory cells that can then mount secondary responses.
Line 3 · 21.5 Active and passive humoral immunity

21.5 Active and passive humoral immunity: who made the antibodies?

Humoral immunity
↓
Active
Your own B cells encounter antigens and produce antibodies against them
↓
B Naturally acquired
Infection; contact with pathogen
Artificially acquired
Vaccine; dead or attenuated pathogens
Passive
Ready-made antibodies are introduced into your body
↓
motherfetus / infant Naturally acquired
Antibodies passed from mother to fetus via the placenta, or to infant in her milk
Artificially acquired
Injection of exogenous antibodies (gamma globulin)
Active immunity establishes immunological memory. Passive immunity never does.

Active humoral immunity

  • When your B cells encounter antigens and produce specific antibodies against them, you are exhibiting active humoral immunity. It is acquired in two ways.
  • Naturally acquired: you get an actual bacterial or viral infection, during which time you may develop symptoms of the disease and suffer a little (or a lot).
  • Artificially acquired: you receive a vaccine. Once researchers realized that secondary responses are so much more vigorous than primary responses, the race was on to develop vaccines to "prime" the immune response by providing a first encounter with the antigen.

Vaccines

  • Most vaccines contain pathogens that are dead or attenuated (living, but extremely weakened), or their components.
  • Some new vaccines (for example for COVID-19) contain mRNA that codes for a viral protein. Your own cells make many copies of that protein, which act as antigens to generate an immune response.
  • Two benefits. Their weakened antigens provide functional antigenic determinants that are both immunogenic and reactive. And they spare us most of the symptoms and discomfort of the disease that would otherwise occur during the primary response.
  • Vaccine booster shots are used in some cases to intensify the immune response at later encounters with the same antigen.
  • Community (herd) immunity: if enough people in a population become immune to a particular contagious disease (by vaccination or infection), the likelihood of the disease spreading in that population decreases significantly. This helps protect members of the population who lack immunity, such as people with weakened immune systems.
  • Vaccines have wiped out smallpox and have substantially lessened the illness caused by former childhood killers such as whooping cough, polio and measles. They have dramatically reduced hepatitis B, tetanus, influenza and pneumonia in adults, but immunization of adults in the U.S. has a much lower priority than that of children. As a result, more than 65,000 Americans die each year from preventable infections.
  • Shortcomings. The biggest is that vaccines are not always as effective or long-lasting as we would like. This is usually not the vaccine's fault, but is often because mutations in viruses (such as SARS-CoV-2, the virus that causes COVID-19, and influenza virus) change the shape of the antigen that the vaccine targets. In some individuals, contaminating proteins (for example egg albumin) cause allergic responses to the vaccine.

Passive humoral immunity

  • Passive humoral immunity differs from active immunity in both the antibody source and the degree of protection. Instead of being made by your plasma cells, ready-made antibodies are introduced into your body.
  • As a result, your B cells are not challenged by antigens, immunological memory does not occur, and the protection provided by the "borrowed" antibodies ends when they naturally degrade in the body.
  • Naturally acquired: antibodies cross the placenta to the fetus, or are ingested by the infant with breast milk. For several months after birth, the baby is protected from all the antigens to which the mother has been exposed.
  • Artificially acquired: exogenous antibodies (from outside your own body) are given as gamma globulin, harvested from the plasma of an immune donor. Your slides: injection of serum, such as gamma globulin.
  • Exogenous antibodies are used to prevent hepatitis A (antiserum), and to treat poisonous snake bites (antivenom) and botulism, rabies and tetanus (antitoxin), because these rapidly fatal diseases would kill a person before active immunity could be established.
  • The donated antibodies provide immediate protection, but their effect is short-lived (two to three weeks).
Line 3 · 21.5 Antibodies

21.5 Antibodies: one Y-shaped design, five classes

Variable (V) region Constant (C) region
antigen-binding site antigen-binding site light chain (L) heavy chain (H) variable (V) region constant (C) region hinge region stem region disulfide bonds

What antibodies are

  • Antibodies, also called immunoglobulins (Igs), constitute the gamma globulin part of blood proteins.
  • They are soluble proteins secreted in response to an antigen by effector B cells called plasma cells, and they bind specifically with that antigen.
  • The B cell's antigen receptor is a membrane-bound antibody.
  • Antibodies are formed in response to an incredible number of different antigens. Despite their variety, all antibodies can be grouped into one of five Ig classes.

Basic antibody structure

  • Regardless of its class, each antibody consists of four looping polypeptide chains linked together by disulfide (sulfur-to-sulfur, S–S) bonds, which are covalent bonds between sulfur atoms. The four chains combined form a molecule called an antibody monomer, with two identical halves. The molecule as a whole is T or Y shaped. The textbook's structure figure is based on IgG.
  • Two of the chains, the heavy (H) chains, are identical to each other. They have a flexible hinge region at their approximate "middles".
  • The other two chains, the light (L) chains, are also identical to each other, but they are only about half as long as each H chain.
  • The "loops" on each chain are created by disulfide bonds that cause the intervening parts of the polypeptide chains to loop out. Your slides: arms and stems are stabilized by disulfide bonds.
  • Each chain has a variable (V) region at one end and a constant (C) region at the other end. Antibodies responding to different antigens (made by different cells) have very different V regions, but their C regions are the same (or nearly so) in all antibodies of a given class (your slides: identical for all antibodies of a given class).
  • In each arm of the monomer, the V regions of the heavy and light chains combine to form an antigen-binding site with a shape that fits a specific antigenic determinant. So each antibody monomer has two such sites, and the two are identical.
  • The C regions that form the stem of the monomer determine the antibody class and serve common functions in all antibodies. They are the effector regions of the antibody.
  • The effector regions dictate (1) the cells and chemicals of the body the antibody can bind to, and (2) how the antibody class functions to eliminate antigens. For example, some antibodies activate (fix) complement, some circulate in blood while others are found primarily in body secretions, some cross the placental barrier, and so on.

The five classes

The five major immunoglobulin classes are IgG, IgA, IgM, IgE and IgD, designated on the basis of the C regions in their heavy chains. Remember the word GAMED to recall the five Ig types. Each class has different characteristics, biological roles and locations in the body. Key characteristics are in bold.

IgM (pentamer)

  • The first immunoglobulin class secreted by plasma cells during the primary response. This is diagnostically useful: IgM in plasma usually indicates current infection by the pathogen eliciting its formation.
  • Readily activates complement (your slides: fixes complement through the classical pathway).
  • Exists in monomer and pentamer (five united monomers) forms. Penta = five.
  • The monomer serves as an antigen receptor on the B cell surface.
  • The pentamer circulates in blood plasma. IgM in plasma is huge compared to the other antibodies.
  • Numerous antigen-binding sites (10) make it a potent agglutinating agent.

IgA (dimer)

  • The dimer, called secretory IgA, is found in body secretions such as saliva, sweat, intestinal juice and milk (your slides: sweat, mucus, GI juice, milk).
  • Secretory IgA helps stop pathogens from attaching to epithelial cell surfaces (including mucous membranes and the epidermis).
  • IgA occurs in both monomer and dimer (two linked monomers) forms. The monomer exists in limited amounts in plasma.
B

IgD (monomer)

  • Found on the B cell surface.
  • Functions as a B cell antigen receptor, as does IgM.

IgG (monomer)

  • The most abundant antibody in plasma, accounting for 75–85% of circulating antibodies.
  • The main antibody of both secondary and late primary responses.
  • Readily activates complement.
  • Protects against bacteria, viruses and toxins circulating in blood and lymph.
  • Crosses the placenta and confers passive immunity from the mother to the fetus.
mast cellhistamine

IgE (monomer)

  • The stem end binds to mast cells or basophils. Antigen binding to its receptor end triggers these cells to release histamine and other chemicals that mediate inflammation and an allergic reaction. Your slides: the cell degranulates histamine.
  • Secreted by plasma cells in skin, mucosae of the gastrointestinal and respiratory tracts, and tonsils (your slides: abundant there).
  • Only traces of IgE are found in plasma.
  • Levels rise during severe allergic attacks or chronic parasitic infections of the gastrointestinal tract. Your slides: it mediates some allergies and parasitic infections.

Class switching

  • B cells usually switch from making one class of antibody to another as they become plasma cells (your slides: plasma B cells can switch classes). They retain their antigen specificity, so two or more different antibody classes having the same antigen specificity are produced.
  • The first antibody released in the primary response is IgM. Later, plasma cells begin to secrete IgG (for the late primary and secondary responses).
  • During secondary responses, almost all of the Ig protein is IgG.
  • Switching from IgM to IgA or IgE also occurs.
Line 3 · 21.5 Antibody targets and functions

21.5 How antibodies work: they tag and inactivate, others destroy

Antigen Antibody Complement Innate defenses that finish the job
Antigen + antibody
form an antigen-antibody (immune) complex
↓
Inactivates by
Neutralization
Masks dangerous parts of bacterial exotoxins and viruses
↓ enhances
Phagocytosis
Inactivates by
Agglutination
Clumps cell-bound antigens
↓ enhances
Phagocytosis
Inactivates by
Precipitation
Cross-links soluble antigens so they settle out of solution
↓ enhances
Phagocytosis
Triggers
Complement activation
The chief antibody defense against cellular antigens
↓
Enhances phagocytosis
Enhances inflammation
chemotaxis, histamine release
Leads to cell lysis

The big idea

  • Antibodies themselves cannot destroy antigens. They inactivate antigens and tag them for destruction.
  • The common event in all antibody-antigen interactions is the formation of antigen-antibody (immune) complexes.
  • Defensive mechanisms used by antibodies include neutralization, agglutination, precipitation and complement activation (your slides: complement fixation). The textbook calls the first two the most important.
  • A quick way to remember how antibodies work: they have a PLAN of action. Precipitation, Lysis (by complement), Agglutination, Neutralization.
  • Antibodies act against free viruses, red blood cell antigens, bacterial toxins, intact bacteria, fungi and parasitic worms.

Neutralization

  • The simplest defensive mechanism. Antibodies block specific sites on viruses or bacterial exotoxins (toxic chemicals secreted by bacteria).
  • As a result, the virus or exotoxin cannot bind to receptors on tissue cells.
  • Phagocytes eventually destroy the antigen-antibody complexes. Your slides list two protective benefits: it prevents the antigen from binding receptors on tissue cells, and it enhances phagocytosis of the antigen.

Agglutination

  • Because antibodies have more than one antigen-binding site, they can bind to the same determinant on more than one antigen at a time. Your slides: each antibody has two arms, each containing a variable region capable of binding to one antigen.
  • So antigen-antibody complexes can be cross-linked into large lattices. When cell-bound antigens are cross-linked, the process causes clumping, or agglutination, of the foreign cells.
  • IgM, with 10 antigen-binding sites, is an especially potent agglutinating agent (your slides: the most potent agglutinator).
  • Agglutination occurs when mismatched blood is transfused (the foreign red blood cells clump), and it is the basis of tests used for blood typing.
  • Agglutinated complexes facilitate phagocytosis.

Precipitation

  • Soluble molecules (instead of cells) are cross-linked into large complexes that settle (precipitate) out of solution. Your slides: soluble antigens (instead of cell-bound antigens) cross-link two or more antibodies into complexes.
  • Like agglutinated bacteria, precipitated antigen molecules are much easier for phagocytes to capture and engulf than freely moving antigens.

Complement activation

  • The chief (main) antibody defense used against cellular antigens, such as bacteria or mismatched red blood cells.
  • When several antibodies (your slides: two or more) bind close together on the same cell, the complement-binding sites on their stem regions align and complement is activated.
  • Cell lysis: membrane attack complexes (MAC) may insert into the antigenic cell's surface, triggering lysis.
  • Inflammation and opsonization: molecules released during complement activation tremendously amplify the inflammatory response and promote phagocytosis by opsonizing pathogens. This sets into motion a positive feedback cycle that enlists more and more defensive elements.

Homeostatic Imbalance 21.2: parasitic worms are too big for PLAN

IgE 1COAT

IgE antibodies coat the surface of the parasitic worm, marking it for destruction.

eosinophil 2BIND

When eosinophils encounter antibody-coated worms, they bind to the exposed stems of the IgE.

3RELEASE

This triggers the eosinophils to release the toxic contents of their large cytoplasmic granules all over their prey (your slides: degranulation of hydrolytic enzymes and other toxic chemicals).

Parasitic worms

  • Around the world, billions of people are infected by parasitic worms such as Ascaris and Schistosoma. These large pathogens are difficult for our immune systems to deal with. They need different attack strategies: they are too big for the regular PLAN attack, so "PLAN" is insufficient.
  • Antibodies still play a critical role in the worm's destruction, through IgE and eosinophils.

Monoclonal antibodies as clinical and research tools

  • Monoclonal antibodies are commercially prepared pure antibody preparations specific for a single antigenic determinant. They are produced by descendants of a single cell.
  • Your slides: they are produced by hybridomas, cell hybrids that result from fusing a tumor cell and a B cell. The tumor cell drives replication. The B cell encodes an antibody specific to a single antigen.
  • They are essential in research, clinical testing and treatment.
  • They are used to diagnose pregnancy, certain sexually transmitted infections, some cancers, hepatitis and rabies. These monoclonal antibody tests are more specific, sensitive and rapid than other tests.
  • They are also used to treat leukemia and lymphomas, cancers that are present in the circulation and so are easily accessible to injected antibodies.
  • They also serve as "guided missiles" to deliver anticancer drugs only to cancerous tissue, and are used to treat certain autoimmune diseases.

Summary of antibody actions

  • At the most basic level, the race between antibody production and pathogen multiplication determines whether or not you become sick.
  • Forming antigen-antibody complexes does not destroy the antigens. Instead it prepares them for destruction by innate defenses.
  • Antibodies produced by plasma cells are in many ways the simplest, most versatile ammunition of the immune response. Nevertheless, they provide only partial immunity.
  • Their prey are extracellular pathogens: intact bacteria, free viruses and soluble foreign molecules. In other words, pathogens that are free in body secretions and tissue fluid and circulating in blood and lymph.
  • Until recently, the accepted dogma was that antibodies only act extracellularly. We now know that antibodies can act intracellularly as well.
  • Antibodies that are attached to a virus before that virus infects a cell can "hang on" to the virus as it slips inside the cell. There, the antibodies activate intracellular mechanisms that destroy the virus.
  • Even so, antibodies are not very effective against pathogens like viruses and tuberculosis bacilli that quickly slip inside body cells to multiply there. For these intracellular pathogens, the cellular arm of adaptive immunity comes into play.
Slides and textbook differ

Slides: antibodies do not invade solid tissue unless a lesion is present.

Textbook: antibodies never invade solid tissues unless inflammation is present.

Line 3 · 21.6 Cellular immune response

21.6 Cellular immunity: two kinds of naive T cell, three kinds of effector

Immature lymphocyte
red bone marrow
↓ maturation in the thymus ↓
CD4class II MHC CD4 cell
naive T cell
↓ activation
An APC (dendritic cell) presents antigen on a class II MHC protein
↓
Effector cells: helper T cells (TH) or regulatory T cells (TReg)
Helper T cells help activate B cells, other T cells and macrophages, and direct the adaptive immune response. Regulatory T cells moderate the immune response
Memory CD4 cells
CD8class I MHC CD8 cell
naive T cell
↓ activation
An APC (dendritic cell) presents antigen on a class I MHC protein
↓
Effector cells: cytotoxic T cells (TC)
Destroy cells in the body that harbor anything foreign
Memory CD8 cells

What cellular immunity does

  • T cells are best suited for cell-to-cell interactions. When antigens are presented to a T lymphocyte, they provoke a cellular immune response.
  • T cells provide defense against intracellular antigens.
  • Some activated T cells directly kill body cells that are infected by viruses or bacteria, cancerous or abnormal, or foreign (for example transplanted cells).
  • Other T cells release chemicals that regulate the immune response.

CD4 and CD8

  • T cells are a diverse lot, much more complex than B cells in both classification and function.
  • There are two major populations of T cells, based on which of two structurally related cell differentiation (CD) glycoproteins, CD4 or CD8, a mature T cell displays.
  • The CD4 and CD8 glycoproteins are surface receptors, but they are distinct from the T cell antigen receptors. They play a role in interactions between T cells and other cells.
  • The names of the effector cells (helper, cytotoxic, regulatory) are reserved for activated T cells. Naive T cells are simply called CD4 or CD8 cells (by their CD receptor category).

What each becomes when activated

  • When activated, CD4 and CD8 cells differentiate into the three major kinds of effector cells of cellular immunity.
  • CD4 cells usually become helper T cells (TH), which help activate B cells, other T cells and macrophages, and direct the adaptive immune response. Your slides: helper T cells are the most abundant.
  • Some CD4 cells become regulatory T cells (TReg), which moderate the immune response.
  • CD8 cells become cytotoxic T cells (TC), which destroy cells in the body that harbor anything foreign. Most CD8 cells become effectors.
  • In the textbook's figure, activation, the dividing cells and the memory cells are drawn in the lymphoid tissues and organs, and the effector cells in the blood plasma.
  • Activated CD4 and CD8 cells can also become memory T cells. Your slides: memory CD4 cells comprise a small percentage, and a few CD8 cells become memory CD8 cells.
Line 3 · 21.6 MHC proteins and antigen presentation

21.6 MHC proteins: T cells only see antigen that is held up for them

Why presentation is needed

  • Unlike B cells and antibodies, T cells cannot "see" either free antigens or antigens that are in their natural state.
  • T cells can recognize and respond only to processed fragments of protein antigens displayed on surfaces of body cells (APCs and others), on major histocompatibility complex (MHC) proteins.
  • Antigen presentation is necessary for both the activation of naive T cells and the normal functioning of effector T cells. Your slides: antigen presentation initiates T cell activation, and full TC activation requires subsequent co-stimulation from a TH cell.
  • There are two classes of MHC proteins: class I and class II.

Class I versus class II

Class I MHC proteins
Class II MHC proteins
Displayed by all nucleated cells: virtually all body cells except red blood cells (your slides: all body cells including APCs)
Displayed by APCs only: dendritic cells, macrophages, B cells. Less widespread
Recognized by naive CD8 cells and cytotoxic T cells
Recognized by naive CD4 cells and helper T cells
Foreign antigens on it are endogenous: intracellular pathogens, or proteins made by cancerous cells
Foreign antigens on it are exogenous: phagocytized extracellular pathogens
Holds a protein fragment of 8 or 9 amino acids
Holds longer peptides, 14–17 amino acids
Cells displaying foreign antigens on it send this message. If the cell is an APC: "I belong to self, but have captured a foreign invader. This is what it looks like. Kill any cell that displays it."
If the cell is not an APC: "I belong to self, but have been invaded or become cancerous. Kill me!"
Cells displaying foreign antigens on it send this message: "I belong to self, but have captured a foreign invader. This is what it looks like. Help me mount a defense against it."
  • Dendritic cells are an exception: they can present another cell's endogenous antigens on their class I MHC proteins to activate CD8 cells.

How an antigen gets onto class I MHC

proteases 1DEGRADE

Proteases (protein-digesting enzymes) degrade cytoplasmic proteins as part of their natural recycling.

ER 2INTO THE ER

A random sample of the resulting protein fragments is transported into the endoplasmic reticulum (your slides: the rough ER, RER).

MHC I 3BIND

Inside the ER, the peptides bind to newly synthesized class I MHC proteins.

cell surface 4EXPORT

Transport vesicles export the "loaded" class I MHC proteins to the cell surface.

Class I MHC proteins

  • Found on the surface of virtually all body cells except red blood cells. Each has a groove that holds an antigen: a protein fragment of 8 or 9 amino acids (your slides: short, 8–9 amino acid, complementary fragments).
  • All antigens displayed on class I MHC proteins are endogenous antigens: fragments of proteins synthesized inside the cell.
  • In a healthy cell, endogenous antigens are all self-antigens, generally bits of digested cellular proteins (normal proteins of the cell).
  • In an infected cell, endogenous antigens may also include fragments of foreign antigens that are synthesized within the infected cell but "belong to" the pathogen. In a cancerous cell, they can include altered (cancer) proteins.
  • Class I MHC proteins are crucial for both activating naive CD8 cells and "informing" cytotoxic T cells that infectious microorganisms are hiding in body cells (your slides: informing TC cells of virus-infected or cancerous cells). Without them, viruses and certain bacteria that thrive in cells could multiply unnoticed and unbothered.
  • When class I MHC proteins display fragments of our own proteins (self-antigens), cytotoxic T cells passing by get the signal "Leave this cell alone, it's ours!" and ignore them. When they display foreign antigens, they "sound a molecular alarm" that signals invasion.
  • In this signaling the class I MHC proteins both (1) act as antigen holders and (2) form the self part of the self-nonself complexes that cytotoxic T cells must recognize in order to kill.
  • Your slides: class I MHC with foreign antigen is a signal to destroy that cell. They word the two messages to a TC cell this way. If the cell is an APC: "I belong to self but have captured an intruder that looks like this. Kill all cells displaying this antigen." If the cell is not an APC: "I belong to self but am overcome: kill me."

How an antigen gets onto class II MHC

phagolysosome 1DIGEST

The cell engulfs an exogenous antigen. Proteases break it down (your slides: the antigens are hydrolyzed) inside a phagolysosome.

MHC II 2FUSE

Vesicles from the ER (your slides: RER-generated vesicles) containing class II MHC proteins fuse with the phagolysosome.

3BIND

The antigen fragments bind to the groove of the class II MHC proteins.

CD4 4EXPORT

The vesicle is exported to the cell surface, where the class II MHC protein displays its prize for CD4 cells to recognize.

Class II MHC proteins

  • This second type is less widespread. Class II MHC proteins are typically found only on the surfaces of cells that present antigens to CD4 cells: dendritic cells, macrophages and B cells.
  • Like class I, they are synthesized at the ER and bind to peptide fragments. But the peptides they bind are longer (14–17 amino acids) and come from exogenous antigens: antigens from outside the cell that have been engulfed by the cell that displays them.
  • Class II MHC proteins loaded with foreign antigens generally signal CD4 cells that help is required. It is as if they are showing the CD4 cells what the foreign invader "looks like". Most often, the result is that the CD4 cell will help mount a defense against the antigen.
  • Your slides: exogenous antigen means bacteria and other extracellular pathogens.
Slides and textbook differ

One slide: class II MHC is a signal to destroy all cells displaying that antigen on MHC I.

Textbook, and a later slide: class II MHC with foreign antigen signals that help is needed: "Help me mount a defense against it." The "kill any cell that displays it" message belongs to class I MHC on an APC.

MHC restriction

  • CD4 and CD8 cells have different requirements for the class of MHC protein that presents antigens to them. This constraint, acquired during the education process in the thymus, is called MHC restriction.
  • CD4 cells (which usually become helper T cells) are restricted to binding antigens only on class II MHC proteins, which are typically displayed on APC surfaces. Your slides: CD4 cells bind only MHC II, to enlist TH help in completing B and TC activation. B cells elicit their own co-stimulation from TH, and dendritic cells enlist TH in co-stimulating CD8 cells.
  • CD8 cells (which become cytotoxic T cells) are activated by antigen fragments on class I MHC proteins, also found on the surface of APCs. Once activated, cytotoxic T cells look for this same antigen presented on class I MHC proteins located on any cell in the body. Your slides: CD8 cells bind only MHC I (on all body cells).

The APC's dilemma, and cross-presentation

  • The MHC restriction for CD8 cells presents a problem for APCs. As a rule, class I MHC proteins display endogenous antigens, those that originate inside that same cell. So how do APCs obtain endogenous antigens from another cell and display them on class I MHCs to activate CD8 cells?
  • Dendritic cells have the special ability to do this. Your slides call it cross-presentation.
  1. 1

    The dendritic cell engulfs a dying virus-infected or tumor cell. It can also import antigens through temporary gap junctions with infected cells, rather than engulf.

  2. 2

    It frees the antigens from the phagosome, digests them, and transports fragments into the rough ER.

  3. 3

    The antigens bind complementary MHC I in the rough ER.

  4. 4

    It displays the engulfed cell's endogenous proteins on both class I and class II MHCs. The MHC I-antigen complex comes in a vesicle from the rough ER. MHC II comes in a vesicle from the phagolysosome.

Line 3 · 21.6 Activation and differentiation of T cells

21.6 Activating a T cell takes two signals

APC (dendritic cell) T cell Antigen Co-stimulatory molecule
class II MHC 1ANTIGEN PRESENTATION

A dendritic cell engulfs an exogenous antigen, processes it, and displays its fragments on a class II MHC protein.

CD4 co-stimulation 2DOUBLE RECOGNITION

2a The CD4 T cell recognizes the antigen-MHC complex. Both the TCR and the CD4 protein bind to the antigen-MHC complex. 2b Co-stimulatory molecules bind their receptors.

M helper T cells 3CLONE FORMATION

Activated CD4 T cells proliferate (clone) and become memory and effector cells.

Clonal selection of T cells involves simultaneous recognition of self and nonself. Activation of a CD4 cell is shown here; activation of CD8 cells is similar.

Both signals, or nothing

Signal 1: antigen binding
plus
Signal 2: co-stimulation
↓
Activation
The T cell enlarges and proliferates to form a clone
Signal 1: antigen binding
with no co-stimulatory signal
↓
Anergy
The T cell becomes tolerant to that antigen and is unable to respond

Step 1 · Antigen binding

  • T cells can only be activated by APCs (unlike B cells, T cells must have antigen presented). Activation is a two-step process involving antigen binding and co-stimulation. Both steps usually occur on the surface of the same APC (your slides: both occur on the same APC), and both are required for clonal selection.
  • T cell antigen receptors (TCRs) bind to an antigen-MHC complex on the surface of an APC. Your slides: the specific MHC varies with the T cell type, MHC I for CD8 cells (which become TC) and MHC II for CD4 cells (which become TH).
  • TCRs must perform double recognition: they must recognize both MHC (self-antigen) and the foreign antigen it displays.
  • The TCR that recognizes (by binding) the nonself-self complex triggers multiple intracellular signaling pathways that lead to T cell activation.
  • Other T cell surface proteins also play a role. The CD4 and CD8 proteins that distinguish the two major T cell groups are adhesion molecules that help bind cells together during antigen recognition. Your slides: the CD proteins also bind the MHC-antigen complex to stabilize the dendritic cell–T cell bond.

Step 2 · Co-stimulation

  • Once antigen binding has occurred, the T cell is stimulated but is still "idling", like a car that has been started but not put into gear.
  • Before it can proliferate to form a clone, it must also bind one or more co-stimulatory signals. These are yet other molecules that appear on the surfaces of APCs in tissues that are damaged or invaded by pathogens.
  • For example, dendritic cells and macrophages sprout co-stimulatory molecules on their surfaces when the innate defenses are being mobilized. The binding of these molecules to specific receptors on a T cell is a crucial co-stimulatory signal.
  • Your slides: TC co-stimulation requires the assistance of TH.
  • If a T cell binds to antigen without receiving the co-stimulatory signal, it becomes tolerant to that antigen and is unable to respond. This state of unresponsiveness to antigen is called anergy. Your slides: anergic T cells become tolerant to that antigen, are unable to divide, and do not secrete cytokines.
  • The two-signal sequence acts as a kind of "two-factor authentication", a safeguard to prevent the immune system from destroying healthy cells. Without it, class I MHC proteins, which occur on all body cells and display peptides from within the cell, could activate cytotoxic T cells, leading to widespread damage of healthy cells.
  • Back to the idling car: it will not go anywhere unless it has been both (1) started and (2) put into gear.

Proliferation and differentiation

  • Once activated by antigen binding and co-stimulation, a T cell enlarges and proliferates. Cytokines released by APCs or by T cells themselves promote this process.
  • Cells of the resulting clone differentiate to perform functions according to their T cell class.
  • This primary response peaks within a week of exposure to the triggering antigen.
  • A period of apoptosis then occurs between days 7 and 30. The activated T cells die off and effector activity wanes as the amount of antigen declines.
  • This wholesale disposal of T cells has a critical protective role, because activated T cells that are no longer needed are potential hazards. They produce huge amounts of inflammatory cytokines, which contribute to increased cell division and may promote cancer in chronically inflamed tissue.
  • Thousands of clone members become memory T cells, persisting perhaps for life and providing a reservoir of T cells that can later mediate secondary responses to the same antigen.

Cytokines: the chemical messengers

What cytokines are

  • The chemical messengers involved in cellular immunity belong to a group of molecules called cytokines, a general term for mediators that influence cell development, differentiation and responses in the immune system. They include interferons (IFNs) and interleukins (ILs).
  • Cytokines include hormone-like or paracrine-like glycoproteins released by a variety of cells. Your slides: glycoprotein messengers of the immune system, secreted by various white blood cells, that mediate the immune response including cell division, differentiation, signaling, inflammation and chemotaxis. They act locally or systemically.
  • Some cytokines promote T cell proliferation. Interleukin 1 (IL-1), released by macrophages, stimulates T cells to liberate interleukin 2 (IL-2) and to synthesize more IL-2 receptors.
  • IL-2 is a key growth factor. Acting on the cells that release it as well as other T cells (your slides: autocrine and paracrine), it sets up a positive feedback cycle that encourages activated T cells to divide even more rapidly.
  • All activated T cells also secrete one or more other cytokines that help amplify and regulate a variety of adaptive and innate immune responses. Some are inflammatory chemicals, and others (such as gamma interferon) enhance the killing power of macrophages.

Interferons alpha (α) and beta (β)

Secreted by many cells (your slides: by a virus-infected cell, in protection of adjacent cells). Have antiviral effects. Activate NK cells.

Interferon gamma (γ)

Secreted by lymphocytes (your slides: from B and T cells). Activates macrophages. Stimulates synthesis and expression of more class I and II MHC proteins. Promotes differentiation of TH cells into TH1.

IL-1

Secreted by activated macrophages. Promotes inflammation and T cell activation. Causes fever (acts as a pyrogen that resets the thermostat of the hypothalamus).

IL-2

Secreted by TH cells. Stimulates T and B cell proliferation, TReg cell development, and NK cell activation. Your slides: stimulates TC proliferation and differentiation.

IL-4

Secreted by TH cells (your slides: by some TH cells). Promotes differentiation to TH2, B cell activation (your slides: completes B cell co-stimulation), and IgE antibody secretion (your slides: switches antibody production to IgE).

IL-5

Secreted by TH cells (your slides: by some TH cells) and mast cells. Activates eosinophils (your slides: attracts and activates them) and promotes IgA antibody secretion (your slides: causes plasma cells to secrete IgA antibodies).

IL-6

A potent pro-inflammatory cytokine. Links innate and adaptive immune responses. Attracts lymphocytes and macrophages. Blockers of this cytokine are used to treat some autoimmune diseases and severe COVID-19. Your slides: promotes inflammation, and comes from various white blood cells as well as non-immune cells.

IL-10

Secreted by macrophages, TH and TReg cells. Inhibits macrophages and dendritic cells. Turns down the cellular and innate immune response.

IL-12

Secreted by dendritic cells and macrophages. Stimulates TC and NK cell activity. Promotes TH1 differentiation.

IL-17

Secreted by TH17 cells. Important in innate and adaptive immunity and in recruiting neutrophils. Involved in inflammation in many autoimmune diseases.

Suppressor factors

A generic term for a number of cytokines that suppress the immune system, for example TGF-β and IL-10.

Transforming growth factor beta (TGF-β)

A suppressor factor similar to IL-10. Stimulates TReg and TH17 cell development.

Tumor necrosis factors (TNFs)

Produced by lymphocytes and in large amounts by macrophages. Promote inflammation. Enhance phagocyte chemotaxis and nonspecific killing. Slow tumor growth by selectively damaging tumor blood vessels. Promote cell death by apoptosis.

Line 3 · 21.6 Helper T cells

21.6 Helper T cells: without them there is no adaptive response

T and B cells Dendritic cell Cytokines

Helping humoral immunity: activating a B cell

Thelper T B MHC II 1BIND

The TH cell binds with the self-nonself complexes of a B cell that has encountered its antigen and is displaying it on MHC II on its surface.

Thelper T B IL-4 and others 2CO-STIMULATE

The TH cell releases interleukins (IL-4 and other cytokines) as co-stimulatory signals to complete B cell activation.

Helping cellular immunity: activating a CD8 cell

Thelper T CD8 1BIND

The TH cell binds the dendritic cell.

Thelper T CD8 co-stimulatorymolecule 2STIMULATE

The TH cell stimulates the dendritic cell to express co-stimulatory molecules.

Thelper T CD8 co-stimulatorymolecule IL-2 3ACTIVATE

The dendritic cell can now activate the CD8 cell, with the help of interleukin 2 secreted by the TH cell. The CD8 cell becomes a TC cell after activation.

The central role

  • Helper T (TH) cells play a central role in adaptive immunity, mobilizing both its humoral and cellular arms.
  • Once activated by an APC presenting antigens, TH cells help activate B and T cells and induce B and T cells to proliferate (your slides: co-stimulate B and TC activation to induce proliferation and differentiation).
  • Without the help of "director" TH cells, there is no adaptive immune response (your slides: no immune response). Their cytokines furnish the chemical help needed to recruit other immune cells.
  • The crucial role of TH cells in immunity is painfully evident when they are destroyed, as in AIDS.

Activation of B cells

  • Helper T cells interact directly with B cells displaying antigen fragments bound to class II MHC receptors. TH and B cells usually must interact directly for full B cell activation. Your slides: the TH binds the B cell's MHC II-antigen complex, and CD4 also binds MHC II to stabilize.
  • Whenever a TH cell binds to a B cell, the TH cell releases cytokines (your slides: IL-4 and other cytokines) that prod the B cells into dividing more rapidly. Then, like the boss of an assembly line, the TH cell signals for antibody formation to begin.
  • B cells continue to divide as long as TH stimulation continues. In this way, helper T cells activate B cells to help unleash their protective potential. Your slides: B cells proliferate (mitosis) and differentiate into plasma cells and memory cells, and plasma cells start secreting antibodies.
  • Some B cells may be activated solely by binding to certain antigens called T cell–independent antigens. Responses to these tend to be weak and short-lived.
  • Most antigens are T cell–dependent antigens, which require T cell help (TH co-stimulation) to activate the B cells to which they bind.

Activation of CD8 cells

  • Like B cells, CD8 cells usually require help from TH cells. TH cells cause dendritic cells to express on their surfaces the co-stimulatory molecules required to activate CD8 cells into destructive cytotoxic T cells.
  • The TH cell also produces interleukin 2, which causes the CD8 cell to proliferate and differentiate into a TC cell.
  • Your slides give it as three cells, four steps and multiple attachments:
  1. 1

    The CD8 cell is bound to the APC by the MHC I-antigen complex to its TCR, stabilized by CD8 to MHC I.

  2. 2

    The TH cell binds the APC via its TCR to the MHC II-antigen complex, stabilized by CD4 to MHC II.

  3. 3

    The TH cell secretes cytokines including IL-2. Dendritic cells express and extrude the co-stimulatory molecule CD80. CD80 binds the CD8 cell's co-stimulatory receptor, CD28.

  4. 4

    The TC cell proliferates and differentiates.

Amplification of innate defenses

  • TH cells also amplify the responses of the innate immune system. For example, they activate macrophages to become more potent killers.
  • The cytokines released by TH cells not only mobilize lymphocytes and macrophages but also attract other types of white blood cells into the area (chemotaxis). Your slides: arriving white blood cells secrete chemokines to attract more white blood cells.
  • As the released chemicals summon more and more cells into the battle, the immune response gains momentum (a positive feedback loop), and the sheer number of immune elements overwhelms the antigens.

Subsets of helper T cells

Which subset develops during TH cell differentiation depends on the type of antigen, the site at which it is encountered, and the cytokine exposure of the differentiating TH cell.

TH1

  • Stimulate inflammation, activate macrophages, and promote differentiation of cytotoxic T cells (your slides: co-stimulating TC).
  • They mediate most aspects of cellular immunity.

TH2

  • Mainly defend against parasitic worms.
  • They mobilize eosinophils and activate immune responses that depend on B cells and antibody formation (your slides: co-stimulate B cells and IgE secretion).
  • They are also the cells that promote allergies (your slides: IgE also promotes allergies).

TH17

  • Link together adaptive and innate immunity by releasing IL-17.
  • IL-17 promotes inflammatory responses against extracellular microbes.
  • May underlie most autoimmune diseases (your slides: may contribute to autoimmune disease).
Line 3 · 21.6 Cytotoxic and regulatory T cells

21.6 Cytotoxic T cells kill; regulatory T cells calm things down

Cytotoxic T cell Target body cell Perforin and granzymes
T C target 1DOCK

The TC identifies foreign antigens on MHC I proteins and binds tightly to the target cell.

2RELEASE

The TC releases perforin and granzyme molecules from its granules by exocytosis.

perforin pore target cell membrane 3PORE

Perforin molecules insert into the target cell membrane, polymerize, and form transmembrane pores (cylindrical holes) similar to those produced by complement activation.

apoptosis 4GRANZYMES ENTER

Granzymes enter the target cell via the pores. Once inside, granzymes activate enzymes that trigger apoptosis.

T C 5DETACH

The TC detaches and searches for another prey.

Cytotoxic T cells

  • Cytotoxic T (TC) cells (activated CD8 cells) are T cells that can directly attack and kill other cells.
  • TC cells roam the body, circulating in and out of the blood and lymph and through lymphoid organs, in search of body cells displaying antigens that the TC cells recognize (your slides: antigen matching their TCR).
  • Targets: mainly virus-infected cells. They also attack tissue cells infected by certain intracellular bacteria or parasites, cancer cells, and foreign cells introduced into the body by blood transfusions or organ transplants.
  • Before the onslaught can begin, the cytotoxic T cell must "dock" on the target cell by binding to a self-nonself complex. All body cells display class I MHC antigens, so TC cells can destroy all infected or abnormal body cells.
  • The attack on foreign human cells, such as those of a graft, is more difficult to explain, because here all of the antigens are nonself. Apparently the TC cells sometimes "see" the foreign class I MHC antigens as a combination of self class I MHC protein bound to foreign antigen.

Two ways to deliver the lethal hit

  • Cytotoxic T cells kill other cells by inducing apoptosis, through two major mechanisms.
  • Perforins and granzymes (the strip above). Your slides: the TC exocytoses perforins and granzymes. Perforins create pores through which granzymes enter the target cell. Granzymes stimulate the target cell to undergo apoptosis.
  • Receptor binding. The TC binds to a specific membrane receptor on the target cell that stimulates the target cell to undergo apoptosis.

Cytotoxic T cells versus NK cells

Cytotoxic T cells
Natural killer (NK) cells
Kill with perforins and granzymes, or by binding a receptor that triggers apoptosis
Use the same key mechanisms to kill their target cells
Look for foreign antigen displayed on class I MHC proteins
Do not look for foreign antigen on class I MHC. They search for other signs of abnormality: the lack of class I MHC, antibodies coating the target cell, or the different surface markers that stressed cells often express
Check the "identity flags" to see if they look the way they are supposed to. Foreign antigens stimulate TC cell attack
Check to make sure each cell has "identity flags". Class I MHC proteins inhibit NK cell attack
  • In short, NK cells stalk abnormal or foreign cells in the body that TC cells cannot "see".
  • Immune surveillance: NK cells and TC lymphocytes roam the body, adhering to and crawling over the surfaces of other cells, examining them for markers they might recognize (your slides: telltale signs of infected or cancerous cells).

Regulatory T cells

  • While TH cells help activate adaptive immune responses, related T cells called regulatory T (TReg) cells dampen the immune response. Your slides: like TH, TReg are CD4 cells that differentiate into different effectors.
  • They act in two ways: by direct contact, or by releasing inhibitory cytokines.
  • Your slides name two inhibitory cytokines. IL-10 inhibits macrophages and dendritic cells. Transforming growth factor beta (TGF-β) suppresses macrophages and dendritic cells and stimulates TReg or TH17 development: TReg when there are no inflammatory signals, TH17 when there are.
  • TReg cells are important in preventing autoimmune reactions, because they suppress self-reactive lymphocytes in the periphery, that is, outside the lymphoid organs. Your slides: they suppress self-reactive lymphocytes and NK cells in lymphoid organs and on the periphery.
  • TReg cells and their subpopulations are hot research topics. Researchers hope to use them to induce tolerance to transplanted tissue and to lessen the severity of autoimmune diseases.
  • Regulatory T cells help to maintain tolerance.
Line 3 · 21.6 Putting it together

21.6 An example of a primary immune response: a virus in the airway

Third line of defense: from the site of infection to a lymph node and back

lymph node site of infection mucous membrane airway virus dendritic cell infected cell CD4 TH B plasma cell antibodies CD8 TC 1234a4b5a5b
1

First line: surface barriers

  • The mucous membrane lining the airways helps prevent the virus from entering the body.
  • Mucus traps viruses.
  • Cilia sweep contaminated mucus toward the pharynx, where it is swallowed and digested.
2

Second line: innate internal defenses

  • Virus-infected cells release interferon to warn nearby uninfected cells.
  • Phagocytes (for example resident macrophages) engulf viruses and "sound the alarm" by releasing inflammatory chemicals.
  • Inflammation brings more immune cells and plasma proteins to the area by dilating arterioles and increasing capillary permeability.
  • Complement activation enhances inflammation and causes opsonization of virus particles.
  • NK cells recognize and kill virus-infected cells.
3

Third line: adaptive defenses

  • 1 Dendritic cells (APCs) engulf viruses and dead virus-infected cells.
  • 2 Dendritic cells migrate to a lymph node, where they activate T lymphocytes.
  • 3 A dendritic cell activates a CD4 cell, which forms a clone of helper T (TH) cells and memory cells.
  • 4a The dendritic cell and a TH cell together activate a CD8 cell, which forms a clone of cytotoxic T (TC) cells and memory cells.
  • 4b A TH cell activates a B cell, which forms a clone of plasma cells and memory B cells.
  • 5a TC cells migrate to the site of infection. They attack and kill the infected cells.
  • 5b Plasma cells release antibodies, which travel (via blood) to the site of infection.

How the two arms finish the job

  • Cellular immunity (via TC cells) targets intracellular viruses by killing infected cells.
  • Humoral immunity targets extracellular (free) viruses.
  • Antibodies neutralize viruses by covering the proteins that allow the virus to bind to and enter our cells. No entry = no infection.
  • Agglutination and complement activation enhance phagocytosis by neutrophils and macrophages.

Cells and molecules of the adaptive immune response

B cell

Lymphocyte that matures in bone marrow. Its progeny (clone members) form plasma cells and memory cells. Its B cell receptor is a membrane-bound antibody.

Plasma cell

Antibody-producing "machine"; produces huge numbers of antibodies. An effector B cell.

Helper T (TH) cell

An effector CD4 T cell central to both humoral and cellular immunity. It stimulates production of cytotoxic T cells and plasma cells, activates macrophages, and acts both directly and indirectly by releasing cytokines.

Cytotoxic T (TC) cell

An effector CD8 T cell that kills invaded body cells and cancer cells.

Regulatory T (TReg) cell

An effector CD4 T cell that slows or stops activity of the immune system. Important in controlling autoimmune diseases; several different kinds.

Memory cell

Descendant of an activated B cell or any class of activated T cell; generated during the initial immune response. May exist in the body for years, enabling it to respond quickly and efficiently to subsequent encounters with the same antigen.

Antigen-presenting cell (APC)

Any of several cell types (dendritic cell, macrophage, B cell) that engulfs and digests antigens that it encounters, then presents parts of them on its plasma membrane (bound to an MHC protein) for recognition by T cells bearing receptors for the same antigen. This function, antigen presentation, is essential for activation of T cells.

Antigen

Substance capable of provoking an immune response. Typically a large, complex molecule (for example a protein or modified protein) not normally present in the body.

Antibody (immunoglobulin or Ig)

Protein produced by a B cell or by a plasma cell. Antibodies produced by plasma cells are released into body fluids (blood, lymph, saliva, mucus, etc.), where they attach to antigens. This causes complement activation, neutralization, precipitation or agglutination, which "marks" the antigens for destruction by phagocytes or complement.

Perforins, granzymes

Released by TC cells. Perforins create large pores in the target cell's membrane, allowing entry of apoptosis-inducing granzymes.

Complement

Group of bloodborne proteins activated after binding to antibody-covered antigens or certain molecules on the surface of microorganisms; enhances the inflammatory response and lyses some microorganisms.

Cytokines

Small proteins that act as chemical messengers between various parts of the immune system.

21.7 Immune problems · Immunodeficiencies

21.7 When the immune system does too little: immunodeficiencies

Immune problems
The immune system can weaken, fail, or act in a way that damages the body
↓

What an immunodeficiency is

  • An immunodeficiency is a congenital or acquired condition that impairs the production or function of immune cells (your slides: immune responders, meaning white blood cells) or certain molecules, such as complement or antibodies.
  • Most immune problems can be classified as immunodeficiencies, autoimmune diseases, or hypersensitivities.
  • In an immunodeficiency disease, minor infections become fatally overwhelming because the immune system is unable to combat them.

Severe combined immunodeficiency (SCID) syndromes: congenital

  • The most devastating congenital immunodeficiencies are a group of related disorders called severe combined immunodeficiency (SCID) syndromes. They result from various genetic defects that produce a marked deficit (shortage) of B and T cells.
  • Your slides list several possible causes: (1) mutations resulting in faulty B cell and T cell receptors (BCRs and TCRs); (2) defective adenosine deaminase (ADA), or a dearth of it, which allows purines to build up and destroy B cells, T cells and NK cells; (3) mutations in genes encoding the cytokines that drive B and T cell proliferation and differentiation; (4) a lack of functional TH cells, which limits B cell activation.
  • Children with SCID have little or no protection against disease-causing organisms. Interventions must begin in the first months of life, because minor infections easily shrugged off by most children make children with SCID deathly ill. Untreated, the condition is fatal.
  • Treatments: transplants of matched donor hematopoietic stem cells (your slides: bone marrow transplants containing matched HSCs) dramatically improve survival rates. Genetic engineering techniques that use viruses (your slides: recombinant virus vectors) to carry corrected genes into the patient's own hematopoietic stem cells can also help.

Acquired immunodeficiencies: Hodgkin's lymphoma and drugs

  • Hodgkin's lymphoma (Hodgkin's disease), a cancer of the B cells, can lead to immunodeficiency by depressing lymph node cells.
  • Your slides give three mechanisms. (1) The tumor cells secrete IL-10, which inhibits macrophages and dendritic cells, and inhibits innate and cell-mediated immunity. (2) The tumor cells secrete galectin-1, which stimulates TReg cells to inhibit the immune response. (3) The tumor cells attract normal white blood cells such as macrophages and eosinophils into the node and retrain them to protect, rather than target, the tumor.
  • Immunosuppressive drugs used in transplantation, and certain drugs used to treat cancer, also suppress the immune system.

AIDS: how HIV takes over a helper T cell

helper THIV 1ENTER

HIV's GP120 binds the CD4 receptor. The envelope and the cell membrane fuse, and HIV enters.

viral RNA 2UNCOAT

HIV is uncoated, releasing its RNA genomes and viral proteins (the enzymes reverse transcriptase, integrase and protease).

RNADNA copy 3COPY TO DNA

The viral enzyme reverse transcriptase makes a DNA copy (cDNA) from the viral RNA.

provirusnucleus 4INTEGRATE

Integrase transports the cDNA into the nucleus and incorporates it into the host genome as a provirus.

viral RNA viral proteins provirus latentactive 5LATENT OR ACTIVE

If the host cell is inactive (a memory cell), HIV remains latent, hidden from the immune system and from drugs. If the host cell is active, the provirus may be replicated, or transcribed and translated with the TH cell's enzymes.

protease 6ASSEMBLE

If the provirus is expressed, viral genomes and proteins are assembled. Protease cleaves the proteins to activate them.

7BUD OUT

New virions bud out of the host, taking an envelope with them from the host's plasma membrane. They search for new TH cells to infect.

The retrovirus life cycle in your slide figure

  1. 1

    The virus carries two identical + strands of RNA and reverse transcriptase inside a capsid and an envelope. The retrovirus enters by fusion between its attachment spikes and the host cell receptors.

  2. 2

    Uncoating releases the two viral RNA strands and the viral enzymes reverse transcriptase, integrase and protease.

  3. 3

    Reverse transcriptase copies viral RNA to produce double-stranded DNA.

  4. 4

    The new viral DNA is transported into the host cell's nucleus, where it is integrated into a host cell chromosome as a provirus by viral integrase. The provirus may be replicated when the host cell replicates.

  5. 5

    Transcription of the provirus may also occur, producing RNA for new retrovirus genomes and RNA that encodes the retrovirus capsid, enzymes and envelope proteins.

  6. 6

    Viral proteins are processed by viral protease. Some of the viral proteins are moved to the host plasma membrane.

  7. 7

    The mature retrovirus leaves the host cell, acquiring an envelope and attachment spikes as it buds out.

The course of the disease

1 Acute infection
2–4 weeks after exposure
Flu-like symptoms in 2/3 of those infected
2 Latent phase
about 10 years
Virus replicating at low levels. Few if any symptoms. TH population gradually destroyed. Antiviral therapy can slow this decline
3 AIDS
appears at about 10–15 years
Diagnosed at a TH count below 200 cells per cubic mm. Fatal within 3 years if untreated. Severe weight loss, night sweats, swollen nodes, opportunistic infections

AIDS and HIV

  • The most devastating acquired immunodeficiency is acquired immune deficiency syndrome (AIDS), which cripples the immune system by interfering with the activity of helper T cells. Your slides: HIV progressively destroys TH cells.
  • AIDS is caused by the human immunodeficiency virus (HIV), a virus transmitted in body secretions, especially blood, semen and vaginal secretions (your slides add milk).
  • HIV commonly enters the body via blood-contaminated needles or during various sexual activities (your slides: sexual intercourse and oral sex; also blood transfusions). An infected mother can also transmit the virus to her fetus or neonate: across the placenta, during parturition, or in breast milk.
  • HIV targets CD4 cells via their CD4 surface proteins. Once inside a CD4 cell, HIV "sets up housekeeping", using the viral enzyme reverse transcriptase to produce DNA from its (viral) RNA.
  • This DNA copy, now called a provirus, inserts itself into the target cell's DNA and directs the cell to crank out new copies of viral RNA and proteins, so that the virus can multiply and infect other cells.
  • In the process, HIV destroys TH cells, depressing both branches of adaptive immunity (your slides: all branches of immunity) and turning the whole immune system topsy-turvy.
  • Your slides, on why losing TH cells is so damaging: TH is essential to the overall immune response. It co-stimulates CD8 activation to TC, co-stimulates B cell activation to plasma cells, and secretes cytokines to activate white blood cells and promote inflammation.
  • The HIV reverse transcriptase enzyme is not very accurate (low replication fidelity) and produces errors rather frequently. This causes HIV's relatively high mutation rate and its ability to develop drug resistance rapidly.
  • No cure for AIDS has yet been found. A number of classes of antiviral drugs are available, and these are often used in combination (the anti-HIV cocktail). Your slides: combined antivirals allow a near-normal lifespan if treated early.
Transplant rejection · textbook 21.6

Organ transplants: the immune system attacks what it sees as foreign

Donor organ
most often an allograft: from a different individual of the same species
↓
Immune rejection
NK cells, macrophages, antibodies and especially T cells act vigorously to destroy any tissue they recognize as foreign
↓ two ways to reduce it ↓
Before: match the tissues
ABO and other blood group antigens are determined. Mismatches usually lead to immediate rejection. Matching donor and recipient MHCs helps minimize long-term rejection
After: immunosuppressive therapy
Many of the drugs kill rapidly dividing cells, such as activated lymphocytes

The details

  • The goal of organ transplantation is to provide patients with a functional organ from a living or deceased donor. This is often the only viable option left in end-stage cardiac or renal disease.
  • Immune rejection presents a particular problem (the major threat), so transplant success depends in part on the similarity of the donor and recipient tissues.
  • The most common type of transplant is the allograft: a graft transplanted from a different individual of the same species.
  • Before an allograft is attempted, the ABO and other blood group antigens of donor and recipient are determined, because these antigens are also present on most body cells and mismatches usually lead to immediate rejection. Your slides: ABO, other blood antigens and MHC antigens are matched as closely as possible.
  • Following surgery the patient is treated with immunosuppressive therapy. Many of the drugs used to suppress rejection kill rapidly dividing (mitosing) cells, and all of them have severe side effects.
  • The major problem is that the patient's suppressed immune system cannot protect the body against malignant cells and foreign invaders. As a result, cancers and overwhelming infections remain common causes of death in transplant patients.
  • Cell-mediated responses reject grafts and foreign organ transplants unless the recipient is immunosuppressed.
  • Your slides list two organ transplant risks. (1) Immunosuppression: it must be sustained lifelong, and it increases the risk of infection and cancer. (2) Graft failure. Best prognosis: rejection after 10 years in 50% of patients.
21.7 Immune problems · Autoimmune diseases

21.7 Autoimmune diseases: friendly fire

Weakly self-reactive lymphocytes survive negative selection
The weeding is thorough, but not too thorough, because some pathogens look somewhat like self
↓ normally kept under control by ↓
The co-stimulation safety check
A T cell needs a co-stimulatory signal on an APC, and that signal is only present if the APC has received "danger" signals alerting it to damage or invasion
Regulatory T cells
Routinely contain the B and T cell response
↓ but two kinds of event can set them off ↓
Foreign antigens resemble self-antigens
Antibodies made against the foreign antigen can cross-react with the self-antigen
New self-antigens appear
Self-proteins not previously exposed to the immune system may appear in the circulation
↓
Autoimmune disease

Foreign antigens that resemble self-antigens: cross-reaction

foreign antigenantibody AGAINST THE FOREIGN ANTIGEN

Antibodies are made against a foreign antigen.

self-antigenon a body cellsame antibody CROSS-REACTS WITH SELF

If the determinants of the foreign antigen resemble those on a self-antigen, the antibodies can cross-react with the self-antigen.

What autoimmunity is

  • Occasionally the immune system loses its ability to distinguish friend (self) from foe (foreign antigens). The artillery of the immune system, like friendly fire, turns against itself.
  • The body produces antibodies (autoantibodies) and sensitized cytotoxic T cells that destroy its own tissues. This is called autoimmunity. If a disease state results, it is an autoimmune disease.
  • Some 5% of adults in North America, two-thirds of them females, are afflicted with an autoimmune disease.

Some important autoimmune diseases

brainlunglungheartpancreaskidneykidneyjointmusclenerveskin Multiple sclerosisCNS myelin(brain and spinal cord) Graves' diseasethyroid gland Myasthenia gravisneuromuscular junction Type 1 diabetes mellituspancreatic beta cells Rheumatoid arthritisjoints Glomerulonephritiskidney Systemic lupuserythematosus (SLE)kidneys, heart, lungs, skin

Rheumatoid arthritis

Systematically destroys joints. Your slides: the trigger is thought to be bacterial or viral antigens resembling GAGs in the joints.

Myasthenia gravis

Impairs communication between nerves and skeletal muscles. Your slides: caused by antibodies that destroy nicotinic receptors at the neuromuscular junction.

Multiple sclerosis

Destroys the myelin of the white matter of the brain and spinal cord (CNS myelin). Your slides: antibodies against Epstein-Barr virus (EBV) erroneously bind CAMs (cell adhesion molecules) in oligodendrocytes.

Graves' disease

Prompts the thyroid gland to produce excessive amounts of thyroxine (hyperthyroidism). Your slides: antibodies against follicular cells mimic TSH.

Type 1 (insulin-dependent) diabetes mellitus

Destroys pancreatic beta cells, resulting in a deficit of insulin and inability to use carbohydrates. Your slides: genetics and pathogen exposure are possible triggers, and TC cells target the beta cells with an assist from TH and B cells.

Systemic lupus erythematosus (SLE)

A systemic disease that particularly affects the kidneys, heart, lungs and skin. Your slides: triggers include genes and environment (UV light, drugs, pathogens and failed apoptosis). The immune dysregulation includes overreactive B and T cells and massive secretion of interferons alpha and beta.

Glomerulonephritis

Damages the kidney's filtration membrane and severely impairs renal function. Your slides: inflammation of the filtration membrane is caused by (1) direct immune attack on the membrane, or (2) indirect damage in clearing antigens or immune complexes trapped in the membrane.

Failure of self-tolerance

  • Every autoimmune disease represents a failure of self-tolerance. Maturing lymphocytes undergo an extensive education (negative selection) that weeds out self-reactive cells.
  • Weakly self-reactive lymphocytes that can detect pathogens resembling self are allowed to survive negative selection. They may cause autoimmune disease if they become activated.
  • The co-stimulation safety check and the presence of regulatory T cells generally keep both humoral and cellular immunity under control. Normally these mechanisms are sufficient, but sometimes self-reactive lymphocytes slip out of control. Your slides: B cells need a TH assist for co-stimulation.
  • Foreign antigens resemble self-antigens. If the determinants of a foreign antigen resemble those on a self-antigen, antibodies made against the foreign antigen can cross-react with the self-antigen. In rheumatic fever, antibodies produced during a streptococcal infection react with heart antigens (your slides: antigens on cardiac myocytes and valvular cells), causing lasting damage to the heart muscle and valves, as well as to joints and kidneys.
  • New studies show an association between multiple sclerosis and the Epstein-Barr virus (EBV) that causes mononucleosis. Antibodies against EBV also bind strongly to a cell adhesion molecule in oligodendrocytes that form myelin.
  • New self-antigens appear. They may be generated by (1) gene mutations that cause new proteins to appear at the external cell surface; (2) changes in the structure (conformation) of self-antigens as a result of hapten attachment or infectious damage; or (3) novel self-antigens, normally hidden behind barriers such as the blood brain barrier, that are released by trauma. These newly generated proteins then become immune system targets.

Treatment of autoimmune diseases

  • The most widely used (traditional) treatments suppress the entire immune system: for example, anti-inflammatory drugs such as corticosteroids.
  • Newer treatments target specific aspects of the immune response. Fortunately, the immune system offers many potential targets because it is so complex. Two widely used approaches: blocking the actions of specific cytokines using antibodies against them or their receptors, and blocking the co-stimulatory molecules required to activate effector cells (your slides: required for the second activation step of B and T cells).
  • Approaches still being developed reestablish self-tolerance by activating regulatory T cells, inducing self-tolerance using vaccines, and destroying self-reactive immune cells by directing antibodies against them.
  • The biggest challenge is selectively blocking autoimmune responses without blocking the responses necessary to combat infection.
21.7 Immune problems · Hypersensitivities

21.7 Hypersensitivities: damage done while fighting a harmless threat

What a hypersensitivity is

  • Hypersensitivities result when the immune system damages tissue as it fights off a perceived threat (such as pollen or animal dander) that would otherwise be harmless to the body. Your slides: they are not directed at self antigens. The immune system perceives a threat in an innocuous foreign antigen and damages self tissues in response.
  • Hypersensitivity is an abnormally intense reaction to an otherwise harmless antigen.
  • People rarely die of hypersensitivities. They just make you miserable.
  • The types are distinguished by (1) their time course and (2) whether they involve antibodies or T cells. Antibodies cause immediate and subacute hypersensitivities. T cells cause delayed hypersensitivities.

The four types side by side

Type I · Immediate (acute)

IgEallergen mast cellhistamine
Time course
Begins within seconds after contact with the allergen. Lasts about half an hour.
Caused by
IgE antibodies on mast cells and basophils.
What it is
Allergies.

Type II · Cytotoxic (subacute)

complementantibodyantigen body cellphagocyte
Time course
Onset 1–3 hours after antigen exposure. Lasts 10–15 hours.
Caused by
IgG and IgM antibodies.
What happens
Antibodies bind to antigens on specific body cells and stimulate phagocytosis and complement-mediated lysis of the cellular antigens.
Example
A transfusion of mismatched blood: complement lyses the foreign red blood cells.

Type III · Immune-complex (subacute)

complementneutrophil immune complexes tissue
Time course
Onset 1–3 hours after antigen exposure. Lasts 10–15 hours.
Caused by
IgG and IgM antibodies.
What happens
Antigens are widely distributed through the body or blood, and the huge number of insoluble antigen-antibody complexes formed cannot be cleared from a particular area. An intense inflammatory reaction severely damages local tissues.
Example
The glomerulonephritis of systemic lupus erythematosus.

Type IV · Delayed

TH cytokinesmacrophage
Time course
Slowest onset: 1–3 days.
Caused by
T cells, not antibodies.
What happens
Inflammation and tissue damage result from the action of cytokine-activated macrophages, and sometimes cytotoxic T cells.
Example
Allergic contact dermatitis (poison ivy). The tuberculosis skin test.

Type I: how an allergy works

Allergen Plasma cell and IgE Mast cell Histamine
allergenbody 1FIRST CONTACT

Sensitization stage. Antigen (allergen) invades the body. This first meeting produces no symptoms.

plasma cellIgE 2IgE IS MADE

Plasma cells produce large amounts of class IgE antibodies against the allergen.

mast cell 3IgE ATTACHES

IgE antibodies attach by their stems to mast cells in body tissues (and to circulating basophils). The mast cell now carries fixed IgE antibodies, and its granules contain histamine.

4SECOND CONTACT

Subsequent (secondary) responses. More of the same antigen invades the body.

histamine 5DEGRANULATION

The antigen combines with (binds and cross-links) the IgE attached to mast cells and basophils. This triggers degranulation and the release of histamine and other chemicals.

fluid mucus airway narrows 6HISTAMINE ACTS

Histamine causes blood vessels to dilate and become leaky, which promotes edema. It stimulates secretion of large amounts of mucus, and it causes smooth muscles to contract. If the respiratory system is the site of antigen entry, asthma may ensue.

Immediate (type I) hypersensitivities

  • Immediate hypersensitivities, also called acute or type I hypersensitivities, are what most of us would call allergies (allo = altered; erg = reaction). An allergen is an antigen that causes an allergic reaction.
  • The initial meeting with an allergen produces no symptoms (it is asymptomatic), but it sensitizes a susceptible person: IgE antibodies are secreted and attach by their stem regions to the surfaces of the body's mast cells and basophils.
  • Later encounters with the same allergen trigger an allergic reaction. The allergen promptly binds and cross-links the IgE antibodies on the surfaces of the mast cells and basophils. They release a flood of histamine and other inflammatory chemicals that together induce the inflammatory response typical of allergy.
  • The three results of histamine: outpouring of fluid from capillaries, release of mucus, and constriction of small respiratory passages (bronchioles).

Local allergic reactions

  • Allergic reactions may be local or systemic (bodywide). Mast cells are abundant in connective tissues of the skin and beneath the mucosa of the respiratory passages and the gastrointestinal tract, and these areas are common sites of local allergic reactions.
  • Symptoms depend on the mode of contact. Histamine causes blood vessels to dilate and become leaky, and is largely to blame for the best-recognized symptoms of allergy: runny nose, itching reddened skin (hives), and watery eyes. Your slides: when the allergen contacts the mucous membrane of the eyes and nasal passages.
  • When the allergen is inhaled, symptoms of asthma appear, because smooth muscle in the walls of the bronchioles (small airways) contracts, constricting those small passages and restricting air flow. Your slides: histamine and leukotrienes from mast cells cause the bronchiolar smooth muscle contraction.
  • When the allergen is ingested in food or via drugs, gastrointestinal discomfort (GI upset) occurs.
  • Over-the-counter antiallergy drugs contain antihistamines that counteract these effects.

Anaphylactic shock: the systemic reaction

  • The systemic response known as anaphylactic shock is fairly rare. It typically occurs when the allergen directly enters the blood and circulates rapidly through the body: for example a bee sting, a spider bite, or injection of a foreign substance (such as penicillin or other drugs that act as haptens).
  • The mechanism is essentially the same as that of local responses, but when mast cells and basophils are enlisted throughout the body, the outcome is life threatening.
  • The bronchioles constrict (and the tongue may swell), making it difficult to breathe. The sudden vasodilation and fluid loss from the blood (your slides: blood pressure plummets from vasodilation and increased capillary permeability) may cause circulatory collapse (hypotensive shock) and death within minutes.
  • Epinephrine is the drug of choice to reverse these histamine-mediated effects.

Subacute hypersensitivities (types II and III)

  • Like the immediate types, subacute hypersensitivities are caused by antibodies, but IgG and IgM rather than IgE. They involve both antibodies and complement. Their onset is slower (1–3 hours after antigen exposure) and the reaction lasts longer (10–15 hours).
  • Cytotoxic hypersensitivities (type II) occur when antibodies bind to antigens on specific body cells and stimulate phagocytosis and complement-mediated lysis of the cellular antigens. Your slides: the IgM or IgG is transferred via blood plasma or serum and binds antigens on specific self cells, which is technically an autoimmune response.
  • Type II hypersensitivity may occur after a patient has received a transfusion of mismatched blood and complement lyses the foreign red blood cells.
  • Immune-complex hypersensitivities (type III) result when antigens are widely distributed through the body or blood and the huge number of insoluble antigen-antibody complexes formed cannot be cleared from a particular area. This may reflect a persistent infection or an autoimmune disease.
  • An intense (massive) inflammatory reaction occurs, complete with complement-mediated cell lysis and cell killing by neutrophils, that severely damages local tissues. Your slides: neutrophils degranulate hydrolytic enzymes and ROS.
  • An example of type III hypersensitivity is the glomerulonephritis of systemic lupus erythematosus.

Delayed hypersensitivities (type IV)

  • Delayed hypersensitivity reactions (type IV) are caused by T cells and take longer to appear (1–3 days) than antibody-mediated hypersensitivity reactions. Your slides: unlike types I to III, type IV is mediated not by B cells (via antibodies) but by TH cells, and because it is cell-mediated it has the slowest onset.
  • Inflammation and tissue damage result from the action of cytokine-activated macrophages, and sometimes cytotoxic T cells. Your slides: TH-secreted cytokines activate macrophages and TC cells.
  • The most familiar examples are those classified as allergic contact dermatitis, which follow skin contact with poison ivy, some metals (nickel in jewelry), and certain cosmetic and deodorant chemicals. These agents diffuse through the skin and attach to self-proteins as haptens.
  • Skin tests for tuberculosis depend on a delayed hypersensitivity reaction. When the tubercle antigens (your slides: inert Mycobacterium tuberculosis antigens) are introduced just under the skin, a small hard lesion forms that persists for days if the person has been sensitized to the antigen. Your slides: the tubercle develops at the injection site within 2–3 days, and the lesion represents an aggregation of T cells and other white blood cells at the site.
Developmental aspects of the immune system

The immune system across the lifespan

Where the stem cells come from
Embryo, weeks 1–9
Immune system stem cells originate in the liver and spleen
Later, and through adult life
Red bone marrow becomes the predominant source of stem cells
How the system changes
Newborn
Depends primarily on antibodies and TH2 lymphocytes
With exposure to microbes
The TH1 system is educated and gets stronger
Late in life
Efficiency begins to wane. The ability to fight infection declines

Development

  • Stem cells of the immune system originate in the liver and spleen during weeks 1–9 of embryonic development. Later, the red bone marrow becomes the predominant (primary) source of stem cells, and it persists in this role into adult life.
  • The lymphocyte precursors become immunocompetent in the thymus and bone marrow, and then populate other lymphoid tissues.
  • The newborn's immune system depends primarily on antibodies and TH2 lymphocytes. The TH1 system is educated and gets stronger as a result of encounters with microbes, both harmful and harmless.
  • If such exposure and education does not occur, immune balance is upset and the TH2 system flourishes, causing the immune system to teeter toward allergies.
  • The desire to keep our children squeaky clean with antibiotics that kill off both harmful and harmless bacteria may derail normal immune development.

Outside influences on immune function

  • Nervous system. The nervous system plays an important role in regulating immune responses. The study of psychoneuroimmunology (links between the brain and the immune system) helps explain how stressors such as depression, emotional stress, sleep deprivation and grief can impair the immune response.
  • Your slides also list physical stress, such as excessive exercise, and insufficient sleep.
  • Diet. Vitamin D is required for CD8 cells to become TC cells. Vitamin D deficiency has been linked with autoimmune diseases such as multiple sclerosis.

Aging

  • The immune system normally serves us well until late in life. Then its efficiency begins to wane and its ability to fight infection declines.
  • Older adulthood brings greater susceptibility to both immunodeficiency and autoimmune diseases. The greater incidence of cancer in older adults may also reflect the progressive failure of the immune system.
  • We do not know why the immune system begins to fail, but the thymus begins to atrophy after puberty. Memory cells accumulate, but the production of naive T and B cells declines with age, possibly because progenitor cells reach the limits of their ability to divide (their mitotic limit). This reduces the body's capacity to respond to new antigens.
  • In many older adults, the immune system enters a state of sustained, low-grade inflammation due to the increased production (overproduction) of inflammatory chemicals. Such chronic inflammation is thought to cause or promote many diseases associated with aging, such as atherosclerosis and Alzheimer's disease.
Check yourself

Replay the picture, then answer

A bacterium with a capsule keeps escaping phagocytes. Which step fails, and what fixes it?

Step 1, adherence. The capsule hides the carbohydrate signature the phagocyte needs to bind. Opsonins (antibodies or complement proteins) coat the bacterium and give the phagocyte handles to grab.

Which lines of defense are innate, and what does the adaptive line have that they do not?

Lines 1 and 2 are innate (nonspecific). Line 3 is adaptive (specific): it attacks particular foreign substances, has memory, and takes longer to react.

If the cilia of the upper respiratory tract stopped beating, what job would go undone?

Mucus loaded with dust and bacteria would no longer be swept toward the mouth, so it would not be kept out of the lower respiratory passages.

The tuberculosis bacterium survives inside the phagolysosome. What is the backup plan, and which cell triggers it?

Helper T cells stimulate the macrophage to produce a respiratory burst: free radicals, oxidizing chemicals, and a rise in pH and osmolarity that activates protein-digesting enzymes.

After a fight with bacteria, which is more likely to still be alive: the neutrophil or the macrophage? Why does that matter?

The macrophage. Neutrophils destroy themselves in the process of killing, while macrophages are robust and survive. The late-arriving macrophages replace the dying neutrophils and continue with debris removal before repair.

An NK cell meets two body cells. One has its MHC proteins, one does not. What happens to each, and how?

The MHC proteins on the first cell inhibit NK cell attack. The cell lacking this "self" protein is treated as abnormal: the NK cell contacts it directly and induces apoptosis. NK cells are not phagocytic.

Trace how one injury produces redness, heat, swelling and pain.

Inflammatory chemicals dilate arterioles, causing hyperemia: redness and heat. They also make capillaries leaky, so exudate seeps into the tissue: swelling (edema). The swelling presses on nerve endings: pain. Pain also comes from bacterial toxins and from prostaglandins and kinins.

Put these in order and say what each one is: chemotaxis, margination, leukocytosis, diapedesis.

Leukocytosis: neutrophils are released from bone marrow into the blood. Margination: they cling to the capillary wall using CAMs. Diapedesis: they flatten and squeeze out between endothelial cells. Chemotaxis: they follow the chemical trail to the injury.

A virus-infected cell releases interferon. Does that save the infected cell? Who benefits?

No. The infected cell is killed by the virus. Its interferon binds receptors on neighboring cells, which then make antiviral proteins that block viral reproduction. The protection is not virus-specific.

All three complement pathways converge on one protein. Which one, what does it split into, and what does each piece do?

C3, which splits into C3a and C3b. C3b opsonizes pathogens and triggers insertion of the membrane attack complex (C5b–C9), which lyses the cell. C3a (with C5a) amplifies inflammation by stimulating histamine release.

How is fever different from inflammation, and what starts it?

Fever is systemic; inflammation is localized. White blood cells and macrophages exposed to foreign substances secrete pyrogens, which raise the hypothalamic set point.

The innate system is always ready. Why can the adaptive system not react right away the first time?

It must first "meet" the specific foreign substance: it has to be primed by an initial exposure to that antigen, and priming takes time. Only then can it protect the body against that substance.

Name the characteristics that set adaptive defenses apart from innate defenses.

Adaptive defenses involve B and T lymphocytes, are specific (recognize and target particular antigens), are slow to mobilize, have memory (a stronger reaction to later encounters with the same antigen), and are systemic (not restricted to the initial infection site). Your slides stress three: specific, systemic, memory.

Humoral or cellular: which arm handles a free virus floating in the blood, and which handles a virus-infected body cell? What provides the protection in each?

The free virus is an extracellular target, so humoral immunity: antibodies circulating in body fluids bind it, inactivate it temporarily and mark it for destruction by phagocytes or complement. The infected cell is a cellular target, so cellular immunity: living cells, the T lymphocytes, act directly by killing the infected cell or indirectly by releasing chemicals.

What is the difference between a complete antigen and a hapten?

A complete antigen has both immunogenicity (it stimulates specific lymphocytes to proliferate) and reactivity (it reacts with the activated lymphocytes and the antibodies released). A hapten, or incomplete antigen, is a small molecule that is not immunogenic by itself. It must link up with one of the body's own proteins before the immune system responds to it.

Slides and textbook differ. Textbook: alone, a hapten has reactivity but not immunogenicity. One slide: alone, a hapten is immunogenic but not reactive, and becomes reactive when combined with a protein.

A large protein is a strong antigen, but a large piece of plastic is not. Why?

Acting as an antigen depends on both size and complexity. A large protein has hundreds of chemically different antigenic determinants, which gives it high immunogenicity and reactivity. A plastic is large but simple: many identical, regularly repeating units, so it has little or no immunogenicity.

What marks a cell as "self", and why would your cells be attacked in another person's body?

Self-antigens on the cell surface, including the glycoproteins called MHC proteins, mark a cell as self. They are not antigenic to you, but they are strongly antigenic to other individuals, which is the basis of transfusion reactions and graft rejection. It is unlikely that any two people except identical twins have the same MHC proteins.

What signals that a B or T cell has become immunocompetent?

The appearance of its receptors. When B or T cells become immunocompetent, they display a unique type of receptor on their surface, and all of a cell's receptors are the same, so it is committed to one antigenic determinant.

Where do B cells and T cells mature, and what two things does maturation give them?

B cells mature in the red bone marrow and T cells in the thymus (the primary lymphoid organs). Maturation gives them immunocompetence (able to recognize one specific antigen) and self-tolerance (relatively unresponsive to self-antigens).

In clonal selection, who does the selecting, and what is selected?

The antigen does the selecting. When it binds the particular lymphocyte that has a receptor for it, it selects that lymphocyte for further development. Once activated, that cell proliferates into a clone of identical cells: mostly effector cells, plus a few memory cells.

A developing T cell recognizes self-MHC, and it also recognizes a self-antigen displayed on that MHC. What happens to it, and why?

It passes positive selection (it can recognize self-MHC) but fails negative selection, so it is eliminated by apoptosis. This clonal deletion is the basis of self-tolerance: it keeps T cells from attacking the body's own cells, which would cause autoimmune disorders.

Name the three major APCs. Which is the most effective antigen presenter, and which does not activate naive T cells?

Dendritic cells, macrophages and B lymphocytes. Dendritic cells are the most effective antigen presenter. B cells do not activate naive T cells: they present antigen to a helper T cell to obtain help in their own activation.

How can lymphocytes make up to a billion different antigen receptors from a limited number of genes?

By somatic recombination. Lymphocyte stem cells hold a few hundred gene segments (a "Lego set"), and as each lymphocyte becomes immunocompetent the segments are shuffled and combined in different ways. The newly assembled genes are expressed as the cell's surface receptors.

Why is the secondary response to an antigen so much faster than the primary response?

The immune system has already been primed to the antigen, and sensitized memory cells are already "on alert". The primary response needs a lag of 3 to 6 days while the few B cells specific for the antigen proliferate and their offspring differentiate into plasma cells. In a secondary response a new army of plasma cells is being generated within hours, and the antibody titer peaks within 2 to 3 days instead of about 10.

Which antibody class is most abundant in plasma? Which is secreted first in a primary response? Which is most abundant in secretions? Which sits on mast cells?

IgG is the most abundant in plasma (75–85% of circulating antibodies). IgM is the first class secreted by plasma cells during the primary response. Secretory IgA (the dimer) is the one found in body secretions. IgE binds by its stem end to mast cells or basophils.

Antibodies cannot destroy antigens themselves. Name four ways they still bring about a pathogen's destruction.

PLAN: precipitation, lysis (by complement), agglutination and neutralization. Neutralization, agglutination and precipitation inactivate the antigen and enhance phagocytosis. Complement activation leads to cell lysis and also enhances phagocytosis and inflammation.

A baby is protected by antibodies from its mother's milk. A child is protected after a measles vaccine. Which is active, which is passive, and which one leaves immunological memory?

The baby has naturally acquired passive immunity: ready-made antibodies, no challenge to its own B cells, no memory, and the protection ends when the antibodies degrade. The vaccinated child has artificially acquired active immunity: its own B cells met the antigen and made antibodies. Active immunity establishes immunological memory; passive immunity never does.

Draw a Y for an antibody. Where are the antigen-binding sites, and which region determines the antibody's class?

The two antigen-binding sites are at the tips of the two arms, where the variable (V) regions of a heavy and a light chain combine. The constant (C) regions that form the stem determine the class and are the effector regions.

How do vaccines protect, and what two benefits do they provide?

A vaccine "primes" the immune response by providing a first encounter with the antigen, so a later real encounter gets the faster, stronger secondary response. Its weakened antigens provide functional antigenic determinants that are both immunogenic and reactive, and it spares us most of the symptoms of the disease that would otherwise occur during the primary response.

Class II MHC proteins display what kind of antigens? Which T cells recognize them, and which cells display these proteins?

Exogenous antigens: fragments of phagocytized extracellular pathogens. Naive CD4 cells and helper T cells recognize them. Class II MHC is displayed only by APCs: dendritic cells, macrophages and B cells.

A T cell's receptor binds its antigen on an APC, but the T cell gets no co-stimulatory signal. What happens, and why is the body built that way?

The T cell becomes tolerant to that antigen and is unable to respond: anergy. The two-signal requirement is a safeguard. Without it, class I MHC proteins on healthy body cells, which display peptides from within the cell, could activate cytotoxic T cells and cause widespread damage to healthy cells.

Which type of T cell is the most important in both cellular and humoral immunity, and why?

The helper T cell. It mobilizes both arms: it co-stimulates B cells to complete their activation, it enables dendritic cells to activate CD8 cells into cytotoxic T cells (and supplies IL-2), and its cytokines activate macrophages and recruit other immune cells. Without helper T cells there is no adaptive immune response.

Walk through how a cytotoxic T cell kills a virus-infected cell with perforin and granzymes.

It identifies foreign antigen on the cell's class I MHC and binds tightly. It releases perforin and granzyme molecules from its granules by exocytosis. Perforin inserts into the target membrane and forms pores. Granzymes enter through the pores and activate enzymes that trigger apoptosis. The T cell detaches and searches for another prey.

An abnormal cell displays no class I MHC. Which killer cell looks for antigen on class I MHC, and which one attacks cells that lack it?

Cytotoxic T cells look for foreign antigen displayed on class I MHC proteins. NK cells do not: they search for other signs of abnormality, including the lack of class I MHC. Class I MHC proteins inhibit NK cell attack, so NK cells stalk abnormal cells that cytotoxic T cells cannot "see".

CD8 cells need antigen on class I MHC, but class I normally shows a cell's own internal proteins. How does a dendritic cell activate CD8 cells against a virus infecting other cells?

By cross-presentation. The dendritic cell engulfs dying virus-infected or tumor cells (or imports antigens through temporary gap junctions with infected cells) and displays those cells' endogenous antigens on both its class I and class II MHC proteins.

What makes HIV particularly hard for the immune system to defeat?

It destroys helper T cells, the cells that direct the whole adaptive response, so both branches of adaptive immunity are depressed. Its provirus can sit latent inside inactive (memory) cells, hidden from the immune system and from drugs. And its reverse transcriptase makes frequent errors, giving HIV a relatively high mutation rate and the ability to develop drug resistance.

What event triggers the release of histamine from mast cells in an allergic response?

On a later encounter, the allergen binds and cross-links the IgE antibodies already attached to the surface of the mast cells (and basophils). That triggers degranulation and the release of histamine and other chemicals. The first contact only sensitizes: IgE is made and attaches to the mast cells, with no symptoms.

Sort the four hypersensitivity types by speed, and say what causes each.

Type I (immediate): begins within seconds, lasts about half an hour, caused by IgE on mast cells and basophils. Types II (cytotoxic) and III (immune-complex) are subacute: onset 1–3 hours, lasting 10–15 hours, caused by IgG and IgM. Type IV (delayed): 1–3 days, caused by T cells rather than antibodies.

Lymphocytes are educated to ignore self. Give the two kinds of event that can still lead to an autoimmune disease.

Weakly self-reactive lymphocytes survive negative selection. They can be set off when (1) foreign antigens resemble self-antigens, so antibodies against the foreign antigen cross-react with self (as in rheumatic fever after a streptococcal infection), or (2) new self-antigens appear, from gene mutations, from hapten attachment or infectious damage, or from normally hidden antigens released by trauma.

Why is anaphylactic shock life threatening when a local allergic reaction is not, and what is the treatment?

The mechanism is essentially the same, but the allergen typically enters the blood directly, and mast cells and basophils are enlisted throughout the body. The bronchioles constrict (and the tongue may swell), making it hard to breathe, and sudden vasodilation and fluid loss from the blood may cause circulatory collapse and death within minutes. Epinephrine is the drug of choice.

A transplant patient takes immunosuppressive drugs for life. What does that prevent, and what does it cost?

It suppresses rejection, in which NK cells, macrophages, antibodies and especially T cells destroy tissue they recognize as foreign. The cost: the suppressed immune system cannot protect the body against malignant cells and foreign invaders, so cancers and overwhelming infections remain common causes of death in transplant patients.

Watch it move

Videos

From your slides

Why This Matters: Career Connection

Open the Pearson video
From your slides · 7 minutes

MicroFlix: Immunology

A comprehensive video covering both humoral and cell-mediated immunity in response to rhinovirus (common cold) infection. A concise and yet detailed summary of adaptive immunity.

Open the Pearson video
Outside video · Crash Course · 9 minutes

Immune System, Part 1 (A&P #45)

1:47 skin and mucous membranes. 3:17 phagocytes. 4:29 natural killer cells. 5:16 inflammation and fever.

Where it differs from your class: the intro calls all innate defenses the "first line". Later it matches your class: barriers are the first line and the internal innate defenses the second. It shows margination, diapedesis and chemotaxis without naming them. It does not cover interferons or complement.

Open on the Crash Course site